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Roles of γδ T Cells in Influenza Infections and Methods for TCR Expression and
Characterization
Abstract
"Influenza virus is a significant pathogen in humans and animals with the ability to cause extensive
morbidity and mortality. Exuberant immune responses associated with immune cell migration/activation
and cytokine/chemokine release, can be induced after infections. Recent studies have painted a complex
picture of viral clearance and tissue repair in adults. The immune responses in neonatal influenza
infections and the potential methods to engineer antigen-specific T cells for immunotherapy against
cancers and infections will be the focus of this dissertation." "Compared to adults, infants suffer higher
rates of hospitalization, severe clinical complications, and mortality due to influenza infection. We found
that γδ T cells protected neonatal mice against mortality during influenza infection. γδ T cell deficiency
did not alter viral clearance or interferon-γ production. Instead, neonatal influenza infection induced the
accumulation of interleukin-17A (IL-17A)-producing γδ T cells, which was associated with IL-33
production by lung epithelial cells. Neonates lacking IL-17A-expressing γδ T cells or Il33 had higher
mortality upon influenza infection. γδ T cells and IL-33 promoted lung infiltration of group 2 innate
lymphoid cells and regulatory T cells, resulting in increased amphiregulin secretion and tissue repair. In
influenza-infected children, IL-17A, IL-33, and amphiregulin expression were positively correlated, and
increased IL-17A levels in nasal aspirates were associated with better clinical outcomes. Our results
indicate that γδ T cells are required in influenza-infected neonates to initiate protective immunity and
mediate lung homeostasis." "In addition, transgenic expression of antigen-specific T cell receptor (TCR)
genes is a promising approach for immunotherapy against infectious diseases and cancers. A key to the
efficient application of this approach is the rapid and specific isolation and cloning of TCRs. Current
methods are often labor-intensive, nonspecific, and/or relatively slow. Here, we describe an efficient
system for antigen-specific TCR cloning and CDR3 substitution. We demonstrate the capability of cloning
influenza-specific TCRs within 10 days using single-cell polymerase chain reaction (PCR) and Gibson
Assembly techniques. This process can be accelerated to 5 days by generating receptor libraries,
requiring only the exchange of the antigen-specific CDR3 region into an existing backbone. We describe
the construction of this library for human γδ TCRs and report the cloning and expression of a TRGV9/
TRDV2 receptor that is activated by zoledronic acid. The functional activity of these α and γδ TCRs can
be characterized in a novel reporter cell line (Nur77-GFP Jurkat 76 TCR-null) for screening of TCR
specificity and avidity. In summary, we provide a rapid method for the cloning, expression, and functional
characterization of human and mouse TCRs that can assist in the development of TCR-mediated
therapeutics." "Overall, this dissertation addresses the protective roles of γδ T cells in murine and human
neonatal influenza infections, and establishes the rapid system for TCR characterization, cloning and
expression, which may shed light on T cell adoptive transfer immunotherapy for viral infections."
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ABSTRACT
Influenza virus is a significant pathogen in humans and animals with the ability to
cause extensive morbidity and mortality. Exuberant immune responses associated with
immune cell migration/activation and cytokine/chemokine release, can be induced after
infections. Recent studies have painted a complex picture of viral clearance and tissue
repair in adults. The immune responses in neonatal influenza infections and the potential
methods to engineer antigen-specific T cells for immunotherapy against cancers and
infections will be the focus of this dissertation.
Compared to adults, infants suffer higher rates of hospitalization, severe clinical
complications, and mortality due to influenza infection. We found that γδ T cells
protected neonatal mice against mortality during influenza infection. γδ T cell deficiency
did not alter viral clearance or interferon-γ production. Instead, neonatal influenza
infection induced the accumulation of interleukin-17A (IL-17A)-producing γδ T cells,
which was associated with IL-33 production by lung epithelial cells. Neonates lacking
IL-17A-expressing γδ T cells or Il33 had higher mortality upon influenza infection. γδ T
cells and IL-33 promoted lung infiltration of group 2 innate lymphoid cells and
regulatory T cells, resulting in increased amphiregulin secretion and tissue repair. In
influenza-infected children, IL-17A, IL-33, and amphiregulin expression were positively
correlated, and increased IL-17A levels in nasal aspirates were associated with better
clinical outcomes. Our results indicate that γδ T cells are required in influenza-infected
neonates to initiate protective immunity and mediate lung homeostasis.
In addition, transgenic expression of antigen-specific T cell receptor (TCR) genes
is a promising approach for immunotherapy against infectious diseases and cancers. A
key to the efficient application of this approach is the rapid and specific isolation and
cloning of TCRs. Current methods are often labor-intensive, nonspecific, and/or
relatively slow. Here, we describe an efficient system for antigen-specific TCR cloning
and CDR3 substitution. We demonstrate the capability of cloning influenza-specific
TCRs within 10 days using single-cell polymerase chain reaction (PCR) and Gibson
Assembly techniques. This process can be accelerated to 5 days by generating receptor
libraries, requiring only the exchange of the antigen-specific CDR3 region into an
existing backbone. We describe the construction of this library for human γδ TCRs and
report the cloning and expression of a TRGV9/TRDV2 receptor that is activated by
zoledronic acid. The functional activity of these  and γδ TCRs can be characterized in
a novel reporter cell line (Nur77-GFP Jurkat 76 TCR-null) for screening of TCR
specificity and avidity. In summary, we provide a rapid method for the cloning,
expression, and functional characterization of human and mouse TCRs that can assist in
the development of TCR-mediated therapeutics.
Overall, this dissertation addresses the protective roles of γδ T cells in murine and
human neonatal influenza infections, and establishes the rapid system for TCR
characterization, cloning and expression, which may shed light on T cell adoptive transfer
immunotherapy for viral infections.
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CHAPTER 1.

INTRODUCTION

Background
Immune Responses to Influenza Infections
Influenza virus is a pleomorphic enveloped virus of approximately 100nm in
diameter (Dash and Thomas, 2014), belonging to the Orthomyxoviridae. Influenza virus
contains a genome composed of eight segments of negative-sense, single-stranded RNA
(ssRNA) tightly surrounded by nucleoprotein (NP). The surface haemagglutinin (HA)
and neuraminidase (NA) are the major viral glycoproteins by which the subtype of the
virus is defined. Influenza viruses can infect diverse host species, including pigs, birds,
and humans. In the United States, it has been estimated that there were 49 million
influenza illnesses, 960,000 hospitalizations and 79,000 influenza-associated deaths
during 2017-2018 (Rolfes et al.). Influenza epidemics can seriously affect all populations,
but children younger than 2 years of age and adults aged 65 years or older are the most
vulnerable to influenza infection (Blanton, 2019).
Cellular Responses. Influenza virus causes acute respiratory infection and
significant rates of hospitalization and mortality (Thompson et al., 2004). After infection,
influenza virus is internalized into upper and lower respiratory epithelial cells via
endocytosis. Viral RNAs can be recognized by the infected cell as pathogen-associated
molecular patterns (PAMPs) by numerous pathogen recognition receptors (PRRs), which
in turn can promote downstream cellular responses (Dash and Thomas, 2014).
Following the PRR recognition of influenza viral products by innate and epithelial
cells, the immune system initiates the production and release of various inflammatory
cytokines, including interferons, IL-1β, IL-6, TNF-α, IL-33 and others, which further
induce the activation of dendritic cells (DCs) and macrophages for antigen acquisition
and presentation to trigger the maturation, migration, and stimulation of antigen-specific
adaptive immune responses by CD8 T cells (Duan and Thomas, 2016).
Influenza-specific αβ CD8 T cells play a critical role in eliminating virus-infected
cells via two effector activities, antigen-specific cytotoxicity and cytokine/chemokine
production. T cells use T cell receptors (TCRs) to recognize specific viral peptides
presented by the major histocompatibility complex (MHC) molecules on antigen
presenting cells (APCs). The recognition and engagement of the TCR to the peptideMHC complex triggers downstream cytotoxicity and cytokine production by T cells. The
cytotoxicity is mainly modulated by three routes, including perforin/granzyme-mediated
cytolysis (Fan and Zhang, 2005), FasL/Fas-mediated apoptosis (Topham et al., 1997) and
TRAIL/TRAIL-DR signaling (Brincks et al., 2008; Ishikawa et al., 2005). In addition,
antigen-specific CD8 T cells can also produce various cytokines and chemokines, among
which IFN-γ and TNF-α are the most prominent cytokines that regulate the functions of
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other immune cells and induce the infected cell death (Gruta et al., 2004; Seder et al.,
2008).
Cytokine Storm1. The term "cytokine storm” to describe an immune response to
influenza infection was first used in late 2003 in reference to influenza-associated
encephalopathy (Clark, 2007; Yokota, 2003). Thus far, the influenza-induced cytokine
storm has been linked to uncontrolled pro-inflammatory responses, which induce
significant immunopathology and severe disease outcomes (D’Elia et al., 2013; Liu et al.,
2016; Teijaro, 2014; Tisoncik et al., 2012). As we better understand the varied roles of
individual cytokines, the concept of the cytokine storm has become more complicated.
Beyond the direct effects of these cytokines on different cell types, their cross-regulatory
functions within the cytokine network can have important effects on the outcome of an
infection.
One useful framework for considering the role of cytokines is to divide them by
those that are directly induced by virus infection (primary cytokines) and those that are
induced downstream by other cytokines or features of the immune response (secondary
cytokines). Influenza virus infection in epithelial cells, endothelial cells, and alveolar
macrophages leads to the primary wave of cytokine production, especially type I
interferons (IFNs), which upregulate the expression of numerous interferon-stimulated
genes (ISGs) (Kato et al., 2005). Though originally not a primary focus of influenza virus
biology, endothelial cells expressing the Sphingosine-1-phosphate (S1P1) receptor have
been demonstrated to be key orchestrators of the cytokine storm (Teijaro et al., 2011).
Following the type I IFN release, higher expression of ISGs initiates downstream antiviral responses and subsequent inflammatory cytokine production by innate immune
cells, like dendritic cells (DCs), macrophages, neutrophils, and monocytes. In the
adaptive phase of the immune response, different subsets of T cells and group 2 innate
lymphoid cells (ILC2s) are activated and regulated to secrete the secondary cytokines that
promote viral clearance, tissue homeostasis, and lung repair.
As we develop a comprehensive understanding of the multifaceted roles of innate
and adaptive immune effectors during influenza infection, the traditional “cytokine
storm” should be expanded to encompass the diversity of cytokines promoting
pathogenic and protective immunity, including inducing local inflammation, eliminating
infected cells, modulating cellular and molecular immune responses, and promoting
tissue repair and homeostasis. Beyond the well-established functions of traditional
antiviral cytokines like the IFNs, recent studies have implicated new cytokine subsets as
being relevant to influenza infection. Most of the literature has focused on the strong type
1 immune response induced during infection, but type 2 cytokines have now been
demonstrated to play important roles following infection, including IL-33, IL-5, and
AREG. However, their functions remain, in many cases, ambiguous or controversial,
with significant work needed to define their place in the immune network (Figure 1-1).

1

This section adapted with permission from final submission. Guo, X.J. & Thomas, P.G. Semin
Immunopathol (2017) 39: 541. DOI: https://doi.org/10.1007/s00281-017-0636-y.
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Figure 1-1. Spatial and Temporal Segregation of Cytokine Production after
Influenza Infection.
After internalization into epithelial cells, influenza virus can be detected by innate
immune sensors and trigger downstream immune responses, including tremendous
cytokine production, sometimes called the “cytokine storm”. Cytokines directly induced
in a virally infected cell versus those downstream from other cytokine signaling can be
segregated as primary cytokines and secondary cytokines, respectively. In the primary
cytokine wave, virus-infected lung epithelial, endothelial, and other immune cells
produce type I and III IFNs, IL-1β, IL-18, TNF-α, IL-6, IL-33 and other cytokines,
mainly to limit viral replication and spreading and to initiate downstream immune
responses (bottom panel). Following their recruitment and activation by primary
cytokines, CD8 T cells, NK cells, ILC2s, Tregs, and Th2 cells can secrete the secondary
cytokines IFN-γ, IL-10, amphiregulin, and IL-5 to eliminate virus and virally infected
cells, dampen inflammation, and restore lung function (top panel).
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γδ T Cells and Immunity
Development and Functions of γδ T Cells. γδ T cells are the first T cells to
appear in the thymus during fetal thymic ontogeny. As a subset of T lymphocytes, γδ T
cells develop largely in the thymus, and generate γδ TCR via recombination activating
gene (RAG)-mediated V(D)J recombination. Compared to TCRα and TCRβ chains,
TCRγ and TCRδ chain loci have a small number of functional V gene segments. In mice,
there are 7 Vγ (TRGV1-7) and 10 Vδ (TRDV1, 2, 4, 5, 6, 7, 8, 10, 11 and 12) functional
segments, while the human Vγ chain locus consists 8 segments (TRGV2, 3, 4, 5, 8, 9, 10,
and 11) and 3 Vδ segments (TRDV1-3) (Lefranc et al., 2015). Despite the limited
diversity at the TCRγ and TCRδ chain loci, the potential diversity generated at the
combined CDR3 regions (approximately 1018 combinations) is still higher than that of αβ
TCRs (about 1016), resulting from the multiple D gene segments for recombination and
the variety in CDR3 length of TCRδ chain (Chien et al., 2014).
After the TCR rearrangement, the functional expression of the γδ TCR drives
cells into the γδ T cell lineage with the support of SRY-box13 (SOX13) expression at the
stage of double-negative (DN3) or DN4 stage of thymocyte development. Unlike αβ T
cells, γδ T cells undergo functional pre-programming in the thymus before entering the
periphery, which is dependent on TCR signaling. It has been suggested that strong
agonist-dependent signals, like SKINT1, leads to the loss of SOX13, the upregulation of
the transcription factors, such as nuclear factor of activated T cells (NFAT), nuclear
factor-κB and T-bet, the surface expression of Cluster of Differentiation (CD)-27, and the
capacity to produce interferon-γ (IFN-γ). In contrast, weaker signals tend to differentiate
γδ T cells with higher SOX13 and RORγt expression and the potential to produce IL17A. Following development and differentiation, γδ T cells exit the thymus and populate
the periphery, especially in the mucosal barriers, to function in innate and adaptive
immunity (Vantourout and Hayday, 2013).
Although γδ T cells are considered a relatively small subset of T lymphocytes in
the periphery of healthy humans and mice, numerous publications established the fact
that γδ T cells have vital roles in both innate and adaptive immunity against infectious
diseases and cancers. Firstly, based on their diverse cytokine production, γδ T cells can
regulate immune responses, particularly orchestrating inflammation by IL-17A and IL17F production (Crowe et al., 2009; Roark et al., 2008). Additionally, γδ T cells can lyse
the infected or stressed cells via the production of granzymes and perforins (Bade et al.,
2005). Further, γδ T cells can facilitate IgE production by B cells and promote the
humoral response (Born et al., 2017; Huang et al., 2015). Also, it has been shown that γδ
T cells can produce epithelial growth factors to modulate stromal cell function and
proliferation (Boismenu and Havran, 1994; Jameson and Havran, 2007; Nielsen et al.,
2017; Sharp et al., 2005). Moreover, γδ T cells can trigger dendritic cell maturation
(Acker et al., 2015; Ismaili et al., 2002); lastly, γδ T cells can present antigens for αβ T
cells functioning as antigen presenting cells (Brandes et al., 2005; Himoudi et al., 2012;
Tyler et al., 2017).
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γδ T Cells and Neonatal Immunity. Among newborns and young infants, most
of the global mortality is due to infections, because the hosts are particularly susceptible
to microbes (Dowling and Levy, 2014). By studying the ontogeny of early life immunity,
it has been suggested that the immune system of young hosts tends to have type 2 and
type 17 polarized immune responses and limited type 1 immunity, compared to adults,
possibly for the purpose of avoiding tissue damage from the overwhelming inflammation
during development (Dowling and Levy, 2014; Langrish et al., 2002). Therefore, it is
absolutely necessary to characterize the neonatal immune system for the purpose of
therapeutics.
With this aim, we found the fact that γδ T cells are the first T cells to appear in the
immune system, and can respond to pathogen infections rapidly in different tissues
because of their higher abundance in mucosal tissues and innate cell-like features.
However, only limited research has been done to investigate the functions of γδ T cells in
neonatal immune responses. For examples, it has been indicated that impaired IL-17A
production by γδ T cells in neonatal respiratory syncytial virus (RSV) infections causes a
lack of inflammasome activation and more severe disease outcomes, compared to adults
(You et al., 2008). Additionally, a study found that large numbers of γδ T cells in the
brain of infants after injury, and the depletion of γδ T cells provided protection to the
hosts. However, the production of IL-17A and IFN-γ by γδ T cells was not detected
(Albertsson et al., 2018). Nonetheless, the responses of γδ T cells in neonatal influenza
infections still remain unclear.
γδ T Cells and Influenza Infections. Influenza virus infection induces a typical
Th1 immune response in adult mice, but the response is poorly characterized in neonates.
Neonatal responses to other viral infections such as RSV and to bacterial challenge are
characterized by Th2-type and anti-inflammatory responses (Dowling and Levy, 2014).
The innate immune response to infection consists of diverse effectors, including
cytokines, chemokines, and proteases with important antiviral functions that are
generated rapidly in infected lungs. These effectors are produced by different types of
innate immune cells, including innate lymphoid cells, macrophages, neutrophils, natural
killer cells, and γδ T cells. In acute infections, γδ T cells are the major initial IL-17A
producers (Roark et al., 2008). IL-17A produced by γδ T cells can mediate the
inflammatory response and recruit neutrophils to the inflammatory sites in lungs in
response to pulmonary influenza infection. In one study, although IL-17r-/- mice have
higher body weight after influenza infection, their survival rate is significantly lower.
Also, IL-17r-/- mice have reduced neutrophil emigration and more severe lung damage
(Crowe et al., 2009). Additionally, γδ T cells can boost the adaptive immune response.
The interaction between γδ T cells and DCs leads to the maturation of DCs and the
polarization of γδ T cells (Devilder et al., 2006), which in turn modulates functional
polarization of conventional T cells and promotes B cell responses and antibody class
switching (Pao et al., 1996; Wen et al., 1996). Finally, γδ T cells have the capacity to
maintain tissue homeostasis and contribute to tissue repair. For example, Aryl
hydrocarbon receptor (AhR) is highly expressed by γδ T cells, and AhR activation
promotes IL-22 production, but not IL-17A (Martin et al., 2009). IL-22 – expressing γδ T
cells are particularly important in pulmonary immune responses to prevent pulmonary
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injury, repair damaged lung, and maintain lung homeostasis (Zenewicz and Flavell,
2011).
Since γδ T cells are the first T cells to develop in all the vertebrates and can
protect the host against infections via different mechanisms, their striking ontogeny and
functions suggest their primary contributions to neonatal protection, when conventional
αβ T cell responses are functionally less prominent and DCs are immature. Although the
role of CD8 T cells in clearing influenza infection has been shown in both adults
(Topham et al., 1997) and neonates (You et al., 2008), the response of neonatal CD8 T
cells is less robust in cell number and IFN-γ production than that of adult CD8 T cells,
which further leads to pathogenesis in the infected neonates. It has been reported that γδ
T cells make an important contribution to protect young mice from intestinal parasite
infection (Randolph and Lewis, 2006). However, not much is known about the role of γδ
T cells in neonatal viral infection including influenza. Influenza infection still remains a
significant cause of pulmonary morbidity and mortality, especially in neonates.
Therefore, it is critical to investigate whether γδ T cells confer protection against neonatal
influenza infection.
T Cell Mediated Immunotherapy and Current Techniques
Adoptive T cell transfer (ACT) has emerged as a new therapeutic pillar for
immunotherapy. Host T cells that have been in vitro expanded or TCR-engineered to
generate antigen specific T cells, have been successfully used to control viruses and
tumors in patients (Chapuis et al., 2012; Han et al., 2013; Hinrichs et al., 2009; Kershaw
et al., 2006; Lamers et al., 2011). In vitro expansion of viral or tumor-specific T cells
requires significant time to prepare, and the targets of the TCR are not usually fully
characterized. On the other hand, T lymphocytes with genetically engineered TCRs or
chimeric antigen receptors (CAR) have the advantages of defined high antigen-specificity
and binding affinity. Despite the current techniques to profile and clone TCRs that have
improved and shortened the process, these methods are still largely limited to the nonpaired TCR bulk sequencing, require certain minimum amounts of cell number, and
expansion of isolated cells prior to TCR isolation. Therefore, a new approach, which can
overcome these obstacles, needs to be established to improve T cell mediated
immunotherapy to infectious diseases and cancers.
In addition, current studies have shown increasing interest in determining ligands
to certain TCRs (Di Marco Barros et al., 2016; Karunakaran and Herrmann, 2014;
Vantourout et al., 2018; Vavassori et al., 2013; Willcox and Willcox, 2019), which can
activate or inhibit T cell functions for use as potential drug candidates. Interestingly,
numerous reports have attempted to identify γδ TCR ligands, due to the non-MHC
restricted recognition. However, the limited understanding and flexibility in the CDR3 of
γδ TCR makes the ligand identification more difficult (Willcox and Willcox, 2019).
Hence, the establishment of a robust and efficient system with a reliable TCR activation
readout is needed for the screening of specific TCRs.
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Summary and Aims of Dissertation
Neonates are highly vulnerable to influenza infections with severe mortality. γδ T
cells are the first T cells to develop in ontogeny, and the immune responses are biased to
type 2 immunity, which may render γδ T cells responsive to infections via different
mechanisms from adults. Therefore, we hypothesize that γδ T cells have critical roles in
protecting neonatal mice from influenza virus infection by modulating local
inflammation, innate immune responses, and lung homeostasis. Our aim is to unravel the
functions of γδ T cells and related mechanisms following neonatal influenza infection.
As one of the promising methods for immunotherapy, T cell adoptive transfer has
a great potential to protect hosts against infectious diseases and cancers. By improving
the techniques of paired single-cell TCR characterization, cloning, and CDR3
substitution, our aim is to provide more opportunities for immunotherapy for infectious
diseases and cancers.
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CHAPTER 2.

METHODS AND MATERIALS

Methods Related to Neonatal Influenza Infections2
Mice
C57BL/6J (wild-type) and C57BL/6J.129P2-Tcrdtm1Mom/J (Tcrd-/-) mice were
purchased from the Jackson Laboratory. Il33tm1(KOMP)Vlcg (Il33-/-) embryos were obtained
from the KnockOut Mouse Project (KOMP; https://www.komp.org/) and rederived
using C57BL/6 mice at St. Jude Children’s Research Hospital’s Animal Resource
Center. Tcrd+/-, Il33+/-, and Il17a+/- mice were bred to generate littermate control as well
as homozygous knockout mice. Il17a-/- mice were rederived from mice donated by
Sarah Gaffen and Jay Kolls (University of Pittsburgh), with the agreement of Dr.
Yoichiro Iwakura at the Tokyo University of Science. Both male and female neonates
were infected at the age of 7-days-old, and female adult mice were infected at the age of
8-10 weeks. Infection methods are described below.
Human Samples
For this study, we used a subset of individuals from the FLU09 cohort which has
been previously described (Oshansky et al., 2014). Nasal aspirates were collected at time
of enrollment from 25 pediatric patients with laboratory confirmed influenza virus
infection with no predisposing conditions (48% female, 88% African American, average
age at enrollment = 1.5, age range 0.05 – 7.31, age mean ± STD 1.50 ± 1.47). Patients
included in this study were stratified into mild and severe groups using treatment status,
with 56% of patients having severe influenza illness outcome.
Ethical Compliance for Mouse and Human Study
Animal study protocols were approved by St. Jude Children’s Research Hospital
Committee on Use and Care of Animals. All the mice were bred and maintained at St.
Jude Children’s Research Hospital under specific-pathogen free conditions. For studies
involving human samples, inclusion criteria required that participants meet the clinical
case definition of influenza virus infection at the time of enrollment. This study was
conducted in compliance with 45 CFR 46 and the Declaration of Helsinki. Institutional
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This section adapted with permission from final submission. Guo X.Z., Dash P., Crawford J.C., Allen
E.K., Zamora A.E., Boyd D.F., Duan S., Bajracharya R., Awad W.A., Apiwattanakul N., Vogel P.,
Kanneganti T.D., Thomas P.G. (2018). Lung γδ T cells mediate protective responses during neonatal
influenza infection that are associated with type 2 immunity. Immunity. 49(3):531-544. DOI:
https://doi.org/10.1016/j.immuni.2018.07.011.
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Review Boards of St. Jude Children’s Research Hospital and the University of
Tennessee Health Science Center/Le Bonheur Children’s Hospital approved the study.
Animal Model of Influenza A Infection
Neonatal mice were anesthetized by isoflurane inhalation and infected
intranasally (i.n.) with A/HKx31 [H3N2, A/Aichi/2/68× A/Puerto Rico/8/34 (2 + 6)] in
10µl (0.6x102 EID50/g body weight).
For neonatal EdU experiment, infected neonates were injected intraperitoneal
(i.p.) with 50µl EdU (1µg/µl) diluted in PBS at 8 hrs before tissue harvest.
For neonatal influenza infection with rmIL-17A (low-dose: 100pg/mouse, highdose: 1000pg/mouse) and rmIL-33 (10ng/mouse) administration experiment, Tcrd-/neonates were intranasally infected with A/HKx31 virus mixed with rmIL-17A (421-ML;
R&D) or rmIL-33 (3626-ML; R&D) in 10µl.
For anti-Areg neutralizing experiments, wild-type neonates were infected with
A/HKx31 virus in 10µl i.n. followed by intraperitoneal injection of 2ug of anti-Areg
(AF989; R&D) or normal goat IgG control antibody (AB-108-C; R&D) in 50µl of PBS
on day 4, 6 and 9 after infection.
For adult influenza infection, adult wild-type and Tcrd-/- littermates (8-10 weeks
old) were anesthetized by Tribromoethanol (Avertin) i.p. injection and infected i.n. with
1MLD50 A/Puerto Rico/8/34 virus in 30µl.
Quantification of IAV in Infected Lung Tissue
Tissues were homogenized and centrifuged at 10,000 rpm for 15 mins.
Supernatant from lung homogenates were measured by traditional 50% Tissue culture
Infective Dose assay in Madin-Darby canine kidney (MDCK) cells.
Cytokine Measurement of Mouse Lung Homogenates
Cytokines in the supernatant of lung homogenates were measured by mouse
DuoSet ELISA kits (R&D) or Milliplex assays (Millipore) according to manufacturer's’
instructions. The results were normalized by total protein determined by BCA assay
(Thermo Fisher).
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Flow Cytometry
Mice were euthanized at described timepoints and lungs were collected for
analysis. For analysis of surface markers, cells were stained in PBS containing 2%
(wt/vol) BSA, with TCRγ/δ (GL3; Biolegend), TCRβ (H57-597; Biolegend), CD4
(RM4-5; Biolegend), CD8α (53-6.7; Biolegend), CD3 (17A2; Biolegend), CD90.2 (30H12; Biolegend), CD25 (PC61.5; eBioscience), ST2 (DIH9; Biolegend), CD27
(LG.3A10; Biolegend), CD44 (IM7; Biolegend), CCR6 (29-2L17; Biolegend), Sca-1
(D7; Biolegend), ST2 (DIH9; Biolegend), Lineage cocktail (lin-1; Biolegend), Gr-1
(RB6-8C5; Biolegend), CD11b (M1/70; Biolegend), CD11c (N418; Biolegend), CD31
(390; Biolegend) and CD326 (G8.8; Biolegend). Intracellular IL-17A (eBio17B7,
eBioscience), IFN-γ (XMG1.2, Biolegend), Foxp3 (FJK-16s, eBioscience),
Amphiregulin Biotinylated Antibody (R&D), and Brilliant Violet 421 Streptavidin
(Biolegend) were analyzed by flow cytometry according to the manufacturer’s
instructions. For intracellular cytokine staining, T cells were stimulated for 4 hrs with
Cell stimulation cocktail plus protein transport inhibitors (eBioscience) before
intracellular staining, which is according to the manufacturer's instructions
(eBioscience). Antibody validation profiles are available via 1DegreeBio
(http://1degreebio.org/) or CiteAb (http://www.citeab.com). Flow cytometry data were
acquired on Fortessa (BD Biosciences) and analyzed using FlowJo software (TreeStar).
RNA-Seq
Genomic DNA-free total RNA was extracted from whole, homogenized lungs
using the RNeasy Mini kit (Qiagen). Individually indexed libraries were constructed for
each mouse using the Illumina TruSeq Stranded Total RNA kit, and multiplexed
libraries were sequenced across two Illumina HiSeq lanes, yielding over 580 million
100bp paired-end reads. Reads were mapped to the mm10 genome using STAR (version
2.5.2b; (Dobin et al., 2013) with default parameters, and gene counts were obtained with
HTSeq (version 0.6.1p1; (Anders et al., 2015)) using Gencode comprehensive
chromosomal annotations (vM13). Putative genes, pseudogenes, allosomal genes, and
genes with fewer than 5 counts per million (CPM) were excluded from analyses. Gene
counts were normalized to trimmed mean of M-values (TMM) using edgeR (Robinson
and Oshlack, 2010) and then transformed to log2-CPM and modeled as a function of
genotype (i.e., wild-type, Tcrd-/-) using the limma package to determine differential
expression across conditions (Ritchie et al., 2015). Results were corrected for multiple
testing using the Benjamini and Hochberg method to produce FDR-adjusted p-values.
For Gene Set Enrichment Analysis, each gene was assigned a rank by calculating the
product of the log2-fold change and the inverse of the FDR-adjusted p-value; this ranked
set was then analyzed by GSEA (version 2.2.4; (Subramanian et al., 2005)) using the
GseaPreranked function (1,000 permutations, uncollapsed dataset, classic enrichment
statistic, 500/15 maximum/minimum set sizes) and the mouse NetPath gene set (Merico
et al., 2010). RNA-Seq data were deposited at NCBI GEO under accession GSE99683.
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Quantitative Real-time PCR
RNA of sorted γδ T cells, ILC2s, ST2+CD4+ cells and ST2-CD4+ cells was
isolated using RNeasy Mini kit (Qiagen) and reverse transcribed into cDNA with the
SuperScript Vilo kit® (Invitrogen). Gene expression was assessed using Taqman® Gene
Expression Master Mix according to the manufacturer’s instructions (Applied
Biosystems). All human and mouse primers and probe sets were purchased from
Applied Biosystems. Data were analyzed with the method (Livak and Schmittgen, 2001)
and results with Ct value higher than 35 were considered undetected.
In Vitro Stimulation
Murine lung epithelial cells (LET1s) and human lung epithelial cell line (A549)
were maintained in our laboratory and cultured in DMEM supplemented with 10%
(vol/vol) FBS, 1% (vol/vol) L-Glutamine, and 1% (vol/vol) penicillin-streptomycin. For
in vitro stimulation, LET1 cells were plated overnight and treated with 3MOI of
A/HKx31, and/or 50ng/ml recombinant mouse IL-17A (421-ML; R&D) for indicated
time. For in vitro stimulation of human lung epithelial cells, A549 were plated overnight
and treated with 3MOI of A/Brisbane/10/2007 (H3N2), and/or 50ng/ml recombinant
human IL-17A (7955-IL-025/CF; R&D) for 48 hrs. For the pSTAT3 inhibition assay,
LET1 and A549 cells were stimulated with virus and/or IL-17A with 100µM S3I-201
(SML0330; Sigma), resuspended in DMSO. All samples contained 0.05% DMSO in the
culture medium.
Western Blotting
Proteins were extracted from stimulated cells using RIPA lysis buffer
supplemented with proteinase inhibitors (cOmplete Protease Inhibitor Cocktail,
Cat#11836170001, Sigma). Samples were loaded in 12%–15% SDS-PAGE and
transferred onto PVDF membranes. Blocking was performed in 5% BSA for 1 hr, and
membranes were incubated in primary antibodies overnight at 4°C. Membranes were
incubated with HRP-conjugated secondary antibody for 1hr, and proteins were
visualized using ECL substrate (Thermo Fisher). The primary antibodies were IL-33
(1:500 dilution, AF3626, R&D), pSTAT3 (1:1,000, 9145, Cell Signaling), STAT3
(1:1,000, 9139, Cell Signaling), and β-actin (1:2,000, 8457, Cell Signaling).
Neonatal γδ T cell Transfer Experiment
Neonatal γδ T cells were harvested and sorted from lungs of naive wild-type and
Il17a-/- neonatal littermates. Following sorting, wild-type or Il17a-/- γδ T cells were
resuspended in a concentration of 2x104 cells in 10µl of PBS and transferred to Tcrd-/littermate mice i.n., and a third transfer treatment of plain PBS was used as a control
comparison. After 24 hrs, these Tcrd-/- neonates were anesthetized by isoflurane and
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infected i.n. with A/HKx31 in 10µl (0.6x103 EID50/g body weight). We used the logrank test to assess survival differences as a function of treatment; after finding a
significant effect, we then tested for pairwise differences between: 1) neonates receiving
wild-type and Il17a-/- cells, and 2) between neonates receiving wild-type cells and PBS.
We verified that there were no effects of experimental batch on survival by
independently testing for effects of experiment number.
Single Cell Sorting and Multiplex PCR
Single cell suspension was made from wild-type lungs with mock- or influenza(day 2 or 6) infections and stained with a live/dead exclusion dye (Live/dead aqua,
Tonbo Biosciences), APC-conjugated anti-mouse CD3 (clone: 17A2) and PEconjugated anti-mouse γδTCR (clone: GL3). The stained cells were resuspended in
RNAse inhibitor containing sort buffer (RNAsin, Promega, 200U/µl) and sorted by
gating on γδTCR+CD3+ cells directly into a 384-well PCR plate that had been preloaded
with 1µl of reverse transcription reaction mix [1X SuperScript VILO Reaction Mix
(Thermo Fisher), SuperScript VILO enzyme and 1X0.1% NP40 (Thermo Fisher)] with a
sorter (Model SY3200, Sony Biotech Synergy sorter, Sony Biotech, San Jose, CA). The
last column of the plate was left empty for use as PCR negative controls. After sorting,
plates were sealed and kept on ice until end of the sort experiment, briefly centrifuged at
500g, and stored at −80°C until downstream processing.
Following single-cell sort into a 384 well PCR plate, direct lysis and reverse
transcription were performed using SuperScript Vilo (Invitrogen) as described before
(Guo et al., 2016). The resultant cDNA was subjected to a first round PCR reaction using
a cocktail of TCRVγ region-specific forward and C region-specific reverse primers
(Table 2-1). Using a corresponding internal primer pool, the first round PCR products
were further subjected to a nested PCR (Figure 2-1). The PCR products were purified by
Exonuclease I/Shrimp Alkaline Phosphatase treatment (Dash et al., 2015) and sequenced
as described with a TRGC internal primer using an ABI Big Dye sequencer (Applied
Biosystem) at the Hartwell Center, St Jude Children’s Research Hospital. The sequence
data were analyzed using a custom-built, macro-enabled Microsoft Excel sheet to derive
CDR3 nucleotide and amino acid sequences (available upon request). To determine the
corresponding TRGV-TRGJ usage, the sequence data derived from single cells were
matched against the IMGT database (Lefranc et al., 2009).
Human Samples and Cytokine Measurement
To characterize human cytokines during influenza infection, we utilized nasal
lavages obtained as part of the FLU09 study (Oshansky et al., 2014). FLU09 participants
provided lavages at varying intervals from the day of enrollment through 12 days after
enrollment. For this study, we focused on samples from a subset of infants and children
below the age of 8 years (n = 25) who were verifiably infected with influenza A (pH1 or
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Table 2-1.

Primers Targeting Mouse T Cell Receptor Gamma (TRGV) Genes.

Primer Name
TRGV1-3 For

External Primer Sequence
5’GCAGCTGGAGCAAACTG3’

Internal Primer Sequence
5’CTGAATTATCGGTCACCAG3’

TRGV4 For

5’CAAATATCCTGTAAAGTTTTCATC3’

TRGV5 For

5’GATATCTCAGGATCAGCTCTCC3’

5’GTTTAGAGTTTCTATTATATGTCCT
TGCAAC3’
5’TACCCGAAGACCAAACAAGAC3’

TRGV6 For

5’TCACCTCTGGGGTCATATG3’

5’AGAGGAAAGGAAATACGGC3’

TRGV7 For

5’CAACTTGGAAGAAAGAATAATGTC3’

5’CACCAAGCTAGAGGGGTC3’

TRGC Rev

5’CTTTTCTTTCCAATACACCC3’

5’TCDGGAAAGAACTTTTCAAGG3’
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Figure 2-1. Schematic of Reverse Transcription, Multiplex Nested Single-Cell
PCR and Sequencing.
Complementary DNA (cDNA) from TCRγδ and TCRαβ mRNA was reverse transcribed
directly from the sorted and stored single cells in the PCR plate without any RNA
extraction step. The TCRαβ/ γδ transcripts from each cell were amplified by a multiplex
nested PCR strategy, following which the products were purified by a modified
Exonuclease I - rShrimp alkaline phosphatase. The purified PCR products were
sequenced using the relevant TRAC, TRBC, TRGC or TRDC primer.
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H3). Cells were separated from cell-free/mucus-free supernatants, and samples were
stored at -80°C until analysis. Cytokines were measured in supernatants as follows: IL17A, IL-33, and amphiregulin were assayed by Human IL-17A, IL-33, and amphiregulin
DuoSet ELISA kits (R&D), and the level of IFN-γ was detected by Human Milliplex
assays (Millipore) according to manufacturer instructions. To determine severity of
influenza disease outcome, patients who were admitted to an emergency room or
hospital were considered “severe” cases, whereas all other participants were considered
“mild” ca
Quantification and Statistical Analysis
Data were analyzed with Prism 7.0 software (GraphPad) and presented as mean
± S.E.M. unless otherwise indicated. Experiments were repeated at least twice, as
indicated. Statistical significance was determined by Mann-Whitney test between two
groups. For comparison across three or more groups, non-parametric one-way ANOVA
(Kruskal-Wallis test) was used, and differences between individual groups were
estimated using Dunn’s multiple comparisons test. For the comparison of two groups at
different time points, two-way ANOVA was used, and differences between individual
groups were estimated using Sidak’s multiple comparisons test. To compare relative
weight gain between wild-type and Tcrd-/- neonates from 1-15 days after infection, we
used a linear mixed-effects model via the “lmer” function in the R package lme4 (v1.113) (Bates et al., 2015) and assessed the significance of effects with Wald tests;
specifically, genotype was modeled as a function of relative weight gain, with mixed
effects allowing intercepts to vary across subjects (in order to control for individual
differences among the repeatedly measured mice) and allowing the effect of genotype to
vary across time points. The difference of survival rate was determined using the logrank test. p < 0.05 was considered statistically significant where ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, and n.s., non significant.
For the repertoire analysis, because chi-square tests were not applicable due to
the presence of zero-values in contingency table cells, statistical association across
treatment conditions was assessed using Fisher's exact test as implemented in R
(Clarkson et al., 1993). Overall comparisons across days-post-infection for a given cell
type (i.e., CD27+ or CD27-) were constructed as 3x7 contingency tables representing 3
treatment conditions and 7 possible gene segments. In the case that this overall
comparison was significant, the simple effects were resolved by constructing 2x7
contingency tables for each pairwise comparison. P-values were adjusted to control
family-wise error rate using Holm's method (Holm, 1979).
For human cytokine analyses, we initially focused on the putative correlations
underlying the proposed IL-17A/IL-33/Areg axis, using generalized linear mixed
models with a log-link of the Gaussian distribution, as implemented by the R package
MASS (v7.3-47) (Venables and Ripley, 2002), to investigate correlations among the
adjacent components of the axis (i.e., IL-33 as a function of IL-17A, and Areg as a
function of IL-33). In each case, we also included age, study day, and IFN-γ expression
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as fixed effects, and patient-ID was included as a random effect in order to account for
repeated sampling within patients over the course of the study. We also analyzed IFN-γ
expression as a function of axis cytokines, using both the Gamma and Gaussian
distributions. To investigate potential correlations between cytokine levels and disease
severity, we focused on samples collected on the day at which disease severity was
assessed (i.e., study day 0); for these analyses, we used the natural logarithm
transformation to obtain normally distributed cytokine measures and ages, and we
employed multifactor Analysis of Variance models (R aov function), with age included
as a covariate. For significant effects in aov models, we confirmed equal variances
between groups using an F-test (R var.test function).
Data and Software Availability
The RNA-seq data from whole lung RNA of wild-type and Tcrd-/- neonates (day 8
after infection) has been deposited in the Gene Expression Omnibus (GEO, NCBI) under
accession code GSE99683.
Methods Related to TCR Characterization and Cloning3
Subjects and Peripheral Blood Mononuclear Cells (PBMCs) Samples
Samples were obtained on research protocols approved by St. Jude Children’s
Research Hospital’s institutional review boards (IRB) (Memphis, TN). Peripheral whole
blood was collected from heparinized apheresis rings from healthy immunocompetent
individuals not taking immunomodulatory pharmaceutical agents. PBMCs were isolated
via density gradient centrifugation (GE Healthcare Ficoll-Paque PLUS, Marlborough,
MA), and red blood cells (RBCs) were removed using RBC lysis buffer (8.3g NH4Cl,
1g KHCO3, and 1ml 0.1% Phenol Red in 1L distilled water). Isolated PBMCs were
frozen in -80°C for future use. All PBMCs used in the paper were stored frozen.
Compared to fresh PBMC data from healthy apheresis rings, our frozen PBMCs did not
have a significantly lower success rate for single-cell amplification (data not shown).
Single Cell Sorting and Staining
PBMCs were treated with human FcR blocking reagent (Miltenyi Biotec,
Auburn, CA) on ice for 20 minutes. Human TCRγδ cells were isolated by staining with
PE-conjugated anti-human TCRγ/δ (Biolegend, San Diego, CA, clone: B1), FITC-
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This section adapted with open access permission from final submission. Guo X.Z., Dash P., Calverley
M., Tomchuck S., Dallas M.H., Thomas P.G. (2016). Rapid cloning, expression, and functional
characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis. Mol Ther Methods
Clin Dev. 3:15054. DOI: https://doi.org/10.1038/mtm.2015.54.
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conjugated anti-human CD3 (Biolegend, San Diego, CA, clone: OKT3), a dump gate
consisting of APC-conjugated anti-human CD11b/CD14/CD19 (Biolegend, San Diego,
CA, CD11b clone: ICRF44; Biolegend, San Diego, CA, CD14 clone: HCD14;
Biolegend, San Diego, CA, CD19 clone: HIB19) and Live/Dead Violet exclusion
dye(Invitrogen, Carlsbad, CA, L34955) on ice for 30 minutes. After staining, TCRγ/δ+
CD3+ cells were sorted directly into a 96-well PCR plate (Biorad, Hercules, CA) with a
sorter (Model sy3200, Sony Biotech Synergy sorter, San Jose, CA) by the following
gating strategy: Single cells gate - Lymphocytes gate - Singlets gate – Live/dead gate –
Dump gate (CD11b/14/19) – TCRγδ/CD3 gate (Figure 2-2). The last 2 columns of the
plate were left empty for use as PCR negative controls. After sorting, plates were stored
at −80°C until downstream processing. Human αβ T cells were also isolated using a
similar method by using the staining and gating strategy described in this paper (Wang
et al., 2012).
Reverse Transcription, Multiplex, Nested Single Cell PCR and Sequencing
Complementary DNA (cDNA) from TCRγδ and TCRαβ mRNA was reverse
transcribed directly from the sorted and stored single cells in the PCR plate without any
RNA extraction step using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA) in a
2.5μl reaction mix as per the method described previously (Dash et al., 2011). The
cDNA synthesis was carried out by incubating at 25°C for 5min, 42°C for 30min, and
80°C for 5min. Alternatively, we used the SuperScript® VILO cDNA synthesis kit
(Invitrogen, Carlsbad, CA) which produces a higher success rate for single cell PCR by
incubating the reaction mixture at 25°C for 10min, 42°C for 60min, and 80°C for 5min.
The TCRαβ transcripts from each cell were amplified by a multiplex nested PCR
strategy as described previously (Dash et al., 2011; Wang et al., 2012) For amplification
of TCRγδ transcripts, the overall strategy was similar to the published TCRαβ
amplification, except for the primers described in Tables 2-2 and 2-3We designed 9
TRGV external sense primers, 9 TRGV internal sense primers, 8 TRDV external sense
primers and 8 TRDV internal sense primers targeted for individual TRGV and TRDV
families based on the sequences derived from the IMGT database
(http://www.imgt.org/genedb/; (Lefranc et al., 2009)). For the antisense primer, we
designed single TRGC external, TRGC internal, TRDC external, and TRDC internal
primers complementary to the published TRGC and TRDC sequences in IMGT. Human
TRAV14/DV4, TRAV23/DV6, TRAV29/DV5, TRAV36/DV7, and TRAV38-2/DV8
are shared primers in TRAV and TRDV primer sets. The primers were synthesized by
IDT and stored at -20°C at a stock concentration of 100μmol/l in TE buffer (pH8.0). The
primers for each category (sense external, sense internal of TRGV and TRDV) were
combined so that the final concentration of each primer in the mixture was 10μmol/l.
The antisense primers were diluted to 10μmol/l. The PCR conditions for the TCRγδ
nested PCR were 95°C for 2min, followed by 35 cycles of 95°C for 20s, 53°C for 20s,
and 72°C for 45s, followed by final extension of 72°C for 7min. The PCR products were
run on a 2% agarose gel to check for the success rate of the PCR as well as contamination following which the products were purified by a modified Exonuclease I - rShrimp
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Figure 2-2. Gating Strategy of Human TCRγ/δ+ CD3+ Cells Single Cell Sorting.
Human TCRγδ+ CD3+ cells from PBMC samples were single-cell sorted into 96-well
plate by applying the gating strategy above.
“Single cells gate – Lymphocytes gate – Singlets gate – Live/dead gate – Dump gate
(CD11b/14/19) – TCRγδ+/CD3+ gate”.

Table 2-2.

Primers Targeting Human T Cell Receptor Gamma (TRGV) Genes.

TRGV
Primer Name
HuTRGV3.5 For

External Primer Sequence
5’TCTTCCAACTTGGAAGGG3’

5’GGTCATCTGCTGAAATCAC3’

HuTRGV7 For

5’TCTTCCAACTTGCAAGGG3’

5’GGTCATCTGCTGTAATCACTTG3’

HuTRGVA For

5’GGGTCATCCTGTTTCCAG3’

5’TACCTAAGGACCTGTGTAGAGG3’

HuTRGVB For

5’TGGCCTCCCAAAGTACTG3’

5’TCCTCTTTCTATGTCCCAGG3’

HuTRGV8 For

5’CCAACTTGGAAGGGAGAAC3’

5’AAAATGCCGTCTACACCC3’

HuTRGV9 For

5’CCAGGTCACCTAGAGCAAC3’

5’TGTCCATTTCATATGACGG3’

HuTRGV10 For

5’TTATCAAAAGTGGAGCAGTTC3’

5’CAGCTATCCATTTCCACGG3’

HuTRGV11 For

5’GAACAACCTGAAATATCTATTTCC3’

5’CATATCTTGGAAGGCATCC3’

HuTRGV1.2.4.6 For

5’GGGTCATCTGCTGAAATCAC3’

5’CCAGGAGGGGAAGGC3’

HuTRGC Rev

5’GGTGTTCCCCTCCTGG3’

5’CCCAGAATCGTGTTGCT3’
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Internal Primer Sequence

Table 2-3.

Primers Targeting Human T Cell Receptor Delta (TRDV) Genes.

TRDV
Primer Name
HuTRDV1 For

External Primer Sequence
5’GCCCAGAAGGTTACTCAAG3’

5’AGCAAAGAGATGATTTTCCTTA3’

HuTRDV2 For

5’ATTGAGTTGGTGCCTGAAC3’

5’TATATCAACTGGTACAGGAAGACC3’

HuTRDV3 For

5’TGTGACAAAGTAACCCAGAGTTC3’

5’GGTACTGCTCTGCACTTACGAC3’

HuTRDV4/TRAV14 For

5’CAAACCCAACCAGGAATG3’

5’AGGAAAAGGAGGCTGTGAC3’

HuTRDV5/TRAV29 For

5’GCAAGTTAAGCAAAATTCACC3’

5’CTGCTGAAGGTCCTACATTC3’

HuTRDV6/TRAV23 For

5’TTGATAGTCCAGAAAGGAGG3’

5’CGTTTGACTACTTTCCATGG3’

HuTRDV7/TRAV36 For

5’GACAAGGTGGTACAAAGCC3’

5’ATCTCTGGTTGTCCACGAG3’

HuTRDV8/TRAV38-2 For

5’CAGTCACTCAGTCTCAACCAG3’

5’TCTGGTACAAGCAGCCTC3’

HuTRDC Rev

5’CTTCATATTTACCAAGCTTGACAG3’

5’GATGACAATAGCAGGATCAAAC3’
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Internal Primer Sequence

alkaline phosphatase (ExoSAP-IT®, BioRad, Hercules, CA) method (Bell, 2008) to
eliminate unincorporated primers and dNTPs for high quality DNA sequencing. 1μl of
the single cell PCR product was added into the mixture of 4.6μl of Tris-Cl (50mmol/l,
pH8.0), 0.2μl of Exonuclease I and 0.2μl of rShimp alkaline phosphatase and was
incubated at 37°C for 15min and 80°C for 15min. The purified PCR products were
sequenced using the relevant TRAC, TRBC, TRGC or TRDC primer. A schematic of
the PCR strategy is shown in Figure 2-1.
gBlock® Gene Fragments, Gibson Assembly® and Transformation
The gBlock® gene fragments encoding the library of TRGVs and TRDVs were
obtained from Integrated DNA Technologies (IDT, Coralville, IA). The expression
vector pMICherry (10μg), which was modified from the parental pMIGII (Workman et
al., 2002) by changing GFP to an mCherry reporter, was double digested by EcoR I
(20units) and Xho I (20units) restriction enzymes (New England Biolabs, Ipswich, MA)
at 37°C for 3h as per manufacturer’s instruction. Agarose gel purified-linearized
pMICherry vector (100ng) and 2x TCR gBlock inserts were ligated in a three-way
ligation, including the TCRγ gene, TCRδ gene, and linearized vector by using the
Gibson Assembly® Cloning kit (New England Biolabs, Ipswich, MA) per
manufacturer’s instructions. Two microliters of the ligation mixture was transformed
into DH5α Competent E. coli (New England Biolabs, Ipswich, MA) per manufacturer’s
instructions.
Generation of Human CD3 Construct
Human CD3 δ, γ, ε and ζ genes were amplified from human PBMC cDNA using
the primers in Table 2-4. All the genes were linked together by overlap PCR with
species-specific 2A regions inserted (Szymczak et al., 2004). The types and amino acid
sequences of the 2As used are shown in Table 2-5. The CD3 gene complex was then
cloned into an MSCV-based retroviral vector that contains an IRES (Bettini et al., 2013;
Holst et al., 2006; Persons et al., 1997) and ametrine as a reporter gene.
DNA Isolation, Cell Culture and Transfection
Recombinant pMICherry plasmids with full length TCRαβ or TCRγδ inserts were
isolated in small scale by using a NucleoSpin® Plasmid kit (Clontech, Mountain View,
CA) and in large scale for transfection using a Plasmid Midi kit (Qiagen, Hilden,
Germany) per the manufacturers’ instructions. The Neon® Transfection System was used
to transfect 10μg TCRαβ or γδ DNA in the pMICherry vector into the human Jurkat 76
TCRα-β- cell line (2×107 cells/mL, 100ul) (Heemskerk et al., 2003), followed by three
pulses with a voltage of 1,350V and a width of 10ms. The transfected cells were cultured
for 48h before being assayed for TCRαβ or TCRγδ expression on the surface by FACS
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Table 2-4.

2A Primers Targeting Human CD3δ, γ, ε and ζ Genes.

Primer Name
CD3δ sense
CD3δ antisense
CD3γ sense
CD3γ antisense
CD3ε sense
CD3ε antisense
CD3ζ sense
CD3ζ antisense

Table 2-5.

Primer Sequence
5’CCCTCACTCCTTCTCTAGGCGCCGGAATTCGCCAGGATGGA
ACATAGCACG3’
5’CCACGTCTCCCGCCAACTTGAGAAGGTCAAAATTCAAAGTC
TGTTTCACCGGTCCCTTGTTCCGAGCC3’
5’GAATTTTGACCTTCTCAAGTTGGCGGGAGACGTGGAGTCCA
ACCCAGGGCCCATGGAACAGGGGAAG3’
5’CCTCGACGTCACCGCATGTTAGCAGACTTCCTCTGCCCTCA
GATCTTCTATTCCTCCTCAAC3’
5’CAGAGGAAGTCTGCTAACATGCGGTGACGTCGAGGAGAAT
CCTGGCCCAATGCAGTCGGGCACTC3’
5’GTTTTCTTCCACGTCTCCTGCTTGCTTTAACAGAGAGAAGTT
CGTGGCGGATCCTCCGATGCGTCTCTG3’
5’CTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCC
GGTCCCATGAAGTGGAAAGTG3’
5’GAGGGAGAGGGGCGGAATTGATCCTCGAGCAATTGTTAGCG
AGGGGCCAG3’

Types and Sequences of 2A Regions.

2A Type
F2A (foot-and-mouth disease virus)

2A Amino Acid Sequence
VKQTLNFDLLKLAGDVESNPGP

Separation
CD3δ and CD3γ

T2A (Thosea asigna virus)

EGRGSLLTCGDVEENPGP

CD3γ and CD3ε

P2A (porcine teschovirus-1 )

ATNFSLLKQAGDVEENPGP

CD3ε and CD3ζ
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analysis. The human Jurkat 76 cells TCRα-β- cell line was cultured in complete-RPMI
1640 medium, which is RPMI 1640 with 10% of fetal bovine serum, 1% Penicillin
Streptomycin, and 1% L-glutamine at 37°C and 5% CO2.
Immunofluorescent and Flow Cytometric Analyses
For surface staining, cells (1-5×105) were harvested from culture and washed
with FACS buffer (PBS with 1% of BSA and 0.1% sodium azide) prior to staining. The
cells were treated with human FcR blocking reagent (Miltenyi Biotec, Auburn, CA) on
ice for 20 min, and cells were then treated with various fluorescent conjugated
antibodies against cell surface markers in FACS buffer. Human γδ T cells were stained
with APC-conjugated anti-human TCRγ/δ (Biolegend, San Diego, CA, clone: B1) or
APC-conjugated anti-human TCRα/β (Biolegend, San Diego, CA, clone: IP26) and
Pacific Blue-conjugated anti-human CD3 (Biolegend, San Diego, CA, clone: OKT3).
For influenza-specific tetramer staining, cells (1-5×105) were stained with APCconjugated Influenza-M1 tetramer (Beckman Coulter, Brea, CA, HLA-A*0201,
GILGFVFTL) in FACS buffer at room temperature for 1h prior to surface staining with
the same staining antibodies described above.
Modification of the CDR3 Region by Two-Step Overlap Extension PCR Cloning
The substitution of the CDR3 was carried out by an overlap extension PCR
cloning protocol(Bryksin and Matsumura, 2010). Briefly, we generated a library of
linker DNA by gBlock synthesis at IDT (Table 2-6). The linker DNA consists of
TRGC-2A-TRDVx (X represents the TRDV family) sequence. Using the single cell
PCR products of γ and δ chains of the desired clonotype and the relevant linker gBlock
DNA we carried out an overlap PCR. The PCR reaction was set up and carried out as
follows: 12.5μl 2×Phusion® high-fidelity DNA polymerase (New England Biolabs,
Ipswich, MA), 0.25μl of 100×DMSO, 1μl of 10μmol/l TRGV internal sense primer, 1μl
of TRDV internal antisense primer (Tables 2-2 and 2-3), 1ng of linker DNA, and
deionized H2O up to 25μl. The PCR program was 98°C for 30s; 34 cycles of each at
98°C for 10s, 58°C for 30s, 72°C for 1min; then finally 72°C for 10min. The PCR
products were visualized on a 1% agarose gel, and purified from the gel to use for
cloning into the existing construct with the same TRGV and TRDV family usage. The
reaction conditions used were as follows: 20ng of a TCR construct in pMICherry vector
with identical TRGV and TRDV but an irrelevant CDR3γ and δ, with 50ng of the first
step PCR products, 12.5μl of 2×Phusion® high-fidelity DNA polymerase, 0.25μl of
100×DMSO, and deionized H2O up to 25μl. The PCR conditions used were 98°C for
30s; 17 cycles of each at 98°C for 10s, 65°C for 30s, 72°C for 4min; then finally 72°C
for 10min. The PCR products were incubated with 1μl DpnI enzyme (New England
Biolabs, Ipswich, MA) at 37°C for 1h, and 2-3μl of the digested products transformed
into NovaBlue Singles® competent cells (EMD Millipore, Darmstadt, Germany).
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Table 2-6.

Human TCRγδ Linker DNA Library.

Linker
Sequence
DNA
HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV1

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGCTGTTCTCCAGCCTGCTGTGTGTATTTGTGGCCTTCAGCTA
CTCTGGATCAAGTGTGGCCCAGAAGGTTACTCAAGCCCAGTCATCAGTATCC
ATGCCAGTGAGGAAAGCAGTCACCCTGAACTGCCTGTATGAAACAAGTTGGT
GGTCATATTATATTTTTTGGTACAAGCAACTTCCCAGCAAAGAGATGATTTTC
CTTATTCGCC3’

HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV2

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGCAGAGGATCTCCTCCCTCATCCATCTCTCTCTCTTCTGGGC
AGGAGTCATGTCAGCCATTGAGTTGGTGCCTGAACACCAAACAGTGCCTGTG
TCAATAGGGGTCCCTGCCACCCTCAGGTGCTCCATGAAAGGAGAAGCGATCG
GTAACTACTATATCAACTGGTACAGGAAGACCCAAGG3’

HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV3

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGATTCTTACTGTGGGCTTTAGCTTTTTGTTTTTCTACAG

GGGCACGCTGTGTGACAAAGTAACCCAGAGTTCCCCGGACCAGACGG
TGGCGAGTGGCAGTGAGGTGGTACTGCTCTGCACTTACGACACTG3’
HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV4

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGTCACTTTCTAGCCTGCTGAAGGTGGTCACAGCTTCACTGTG
GCTAGGACCTGGCATTGCCCAGAAGATAACTCAAACCCAACCAGGAATGTTC
GTGCAGGAAAAGGAGGCTGTGACTCTGG3’
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Table 2-6.

Continued.

Linker
Sequence
DNA
HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV5

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGGCCATGCTCCTGGGGGCATCAGTGCTGATTCTGTGGCTTCA
GCCAGACTGGGTAAACAGTCAACAGAAGAATGATGACCAGCAAGTTAAGCA
AAATTCACCATCCCTGAGCGTCCAGGAAGGAAGAATTTCTATTCTGAACTGT
GACTATACTAACAGCATGTTTGATTATTTCCTATGGTACAAAAAATACCCTGC
TGAAGGTCCTACATTCCTGATATC3’

HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV6

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGGACAAGATCTTAGGAGCATCATTTTTAGTTCTGTGGCTTCA
ACTATGCTGGGTGAGTGGCCAACAGAAGGAGAAAAGTGACCAGCAGCAGGT
GAAACAAAGTCCTCAATCTTTGATAGTCCAGAAAGGAGGGATTTCAATTATA
AACTGTGCTTATGAGAACACTGCGTTTGACTACTTTCCATGGTACC3’

HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV7

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGATGAAGTGTCCACAGGCTTTACTAGCTATCTTTTGGCTTCT
ACTGAGCTGGGTGAGCAGTGAAGACAAGGTGGTACAAAGCCCTCTATCTCTG
GTTGTCCACGAGGGAG3’

HuLinker 5’catacctttgtcttcttgagaaatttttcccagatattattaagatacattggcaagaaaagaagagcaacacgattctgggatcc
caggaggggaacaccatgaagactaacgacacatacatgaaatttagctggttaacggtgccagaagagtcactggacaaag
DV8

aacacagatgtatcgtcagacatgagaataataaaaacggaattgatcaagaaattatctttcctccaataaagacagatgtcatc
acaatggatcccaaagacaattggtcaaaagatgcaaatgatacactactgctgcagctcacaaacacctctgcatattacatgta
cctcctcctgctcctcaagagtgtggtctattttgccatcatcacctgctgtctgcttggaagaacggctttctgctgcaatggagag
aaatcaGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAAC
CCCGGTCCCATGGCATGCCCTGGCTTCCTGTGGGCACTTGTGATCTCCACCTG
TCTTGAATTTAGCATGGCTCAGACAGTCACTCAGTCTCAACCAGAGATGTCT
GTGCAGGAGGCAGAGACCGTGACCCTGAGCTGCACATATGACACCAGTGAG
AGTGATTATTATTTATTCTGGTACAAGCAGCCTCCCAG3’

Yellow – TRGC region; Purple – 2A sequence; Gray – TRDV region
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Nur77-GFP Jurkat 76 TCRα-β- Cell Line
To characterize the functionality of TCRαβ or γδ clones, we established the
Nur77-GFP Jurkat 76 TCRα-β- cell line (NJ76 cells). After linearization of a Nur77-GFP
BAC clone (constructed based on pTARBAC)(Moran et al., 2011) by mixing 10μg BAC
DNA, 2μl 10× reaction buffer, 10units of PI-SceI restriction enzyme (New England
Biolabs, Ipswich, MA), and nuclease-free water to make the volume up to 20μl with
incubation at 37°C for 3h and inactivation at 65°C for 20min, we added 80μl of
nuclease-free water, 15μl of sterile sodium acetate (3mol/l, pH7.0), and 300μl of ethanol
to the reaction mixture, and centrifuged at 12,000g for 30min at 4°C. The resulting DNA
pellet was washed with 75% ethanol, air dried, and resuspended by Tris-EDTA buffer
(pH 8.0). We used the Neon® Transfection System (Invitrogen, Carlsbad, CA)
following the manufacturer’s instruction to transfect the linearized BAC DNA into the
human Jurkat 76 TCRα-β- cell line (2×107 cells/mL, 100ul), with three pulses with a
voltage of 1,350V and a width of 10ms. Cells were then cultured in complete-RPMI
1640 medium containing 500ug/ml Geneticin (Invitrogen, Carlsbad, CA) for selection.
Stimulation of KbPB1703+TCRαβ+ NJ76 Cells (PB1-NJ76) by Flu Peptide PB1
NJ76 cell transfected with a murine KbPB1703-specific TCRαβ derived from
influenza-infected mice and transfected cells were incubated with mouse splenocytes
(cell number ratio of PB1-NJ76/splenocytes is 2:1), the influenza PB1703-711 peptide
(1μmol/ml), mouse splenocytes and peptide, and mouse α-CD3 (Biolegend, San Diego,
CA, 2C11; 10μg/ml) and human α-CD28 (Biolegend, San Diego, CA, CD28.2;
10μg/ml) in c-RPMI 1640 medium at 37°C for 4h. The GFP expression in the mouse
TCRαβ + CD3+ cell population was quantified by flow cytometry.
Stimulation of TRGV9/TRDV2-NJ76 Cells by Zoledronic Acid
NJ76 cells transfected with a TRGV9/TRDV2 clone were incubated with 50μg/ml
zoledronic acid (Zometa, Novartis, Basel, Switzerland) in c-RPMI 1640 medium at 37°C
for 3h, washed three times and incubated for 12h. The GFP expression in the TCRγδ +
CD3+ cell population was quantified by flow cytometry.
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CHAPTER 3. LUNG γδ T CELLS MEDIATE PROTECTIVE RESPONSES
DURING NEONATAL INFLUENZA INFECTION THAT ARE ASSOCIATED
WITH TYPE 2 IMMUNITY4
Introduction
Influenza viruses are among the most common and significant pathogens that
underlie human respiratory diseases, with high morbidity and mortality (Taubenberger
and Kash, 2010; Taubenberger and Morens, 2008). These viruses primarily infect
respiratory epithelial cells where, after detection by immune sensors, the host will initiate
innate and adaptive immune responses that guide viral clearance and tissue repair (Dash
and Thomas, 2014; Iwasaki and Pillai, 2014). Whereas viral clearance is primarily
promoted by type 1 immune responses through effector CD8+ T cells (Cerwenka et al.,
1999; Duan and Thomas, 2016; Duan et al., 2015), group 2 innate lymphoid cells (ILC2s)
regulated by interleukin (IL)-33-IL-33R signaling promote type 2 immune responses and
are important for lung homeostasis and repair following influenza infection (Chang et al.,
2011; Gorski et al., 2013; Guo and Thomas, 2017; Le Goffic et al., 2011; Monticelli et
al., 2011). Similarly, regulatory T (Treg) cells and T helper (Th) cells have been
implicated in beneficial influenza immune responses mediated by IL-33-driven tissue
restoration via production of amphiregulin (Areg) (Arpaia et al., 2015). Although the
downstream immune responses and tissue repair process induced by IL-33 have been
well defined, the production and upstream regulation of IL-33 is still unclear.
Compared to adults, infants suffer relatively higher rates of hospitalization, severe
clinical complications, and mortality as a result of influenza infection (Bhat et al., 2005;
Munoz, 2003). The proximate mechanisms guiding these age-dependent differences may
also be related to exaggerated type 2 responses that are characteristic of the infant
immune system (Adkins et al., 2004; Dowling and Levy, 2014; Garcia et al., 2000; Kleer
et al., 2016), mediated by the IL-33 pathway (Kleer et al., 2016; Saluzzo et al., 2017), and
may function to prevent tissue damage owed to excessive inflammation. Thus, the
pathologies concomitant with influenza infection, and their respective therapeutic targets,
likely differ between infants and adults. In adult influenza infection, CD8+ T cells
predominate the antiviral response (Cerwenka et al., 1999; Duan and Thomas, 2016;
Duan et al., 2015), but in infant influenza infection, CD8+ T cells exhibit relatively
reduced functionality (You et al., 2008).
In contrast to CD8+ T cells, γδ T cells are the first T cells to appear in the thymus
during fetal development and have the capacity to recognize a wide range of antigens and
respond rapidly to infections (Chien et al., 2014; Vantourout and Hayday, 2013) even
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Thomas P.G. (2018). Lung γδ T cells mediate protective responses during neonatal influenza infection that
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during infancy; for instance, these cells are known to play important roles in the infant
immune response to RSV infection (Huang et al., 2015) and enterocolitis (Weitkamp et
al., 2014). In mice, γδ T cells are generally categorized according to their secretion of
IFN-γ (Gao et al., 2003), IL-17A (Coffelt et al., 2015; Papotto et al., 2017), or M-CSF
(Mamedov et al., 2018). The IL-17A producers, in particular, are known to play a
prominent role in lung immunity to bacterial infections, where rapid IL-17A production
is critical for the recruitment of protective neutrophil responses (Romagnoli et al., 2016).
For the most part, γδ T cells have not been associated with inducing type 2 immune
effectors. Although γδ T cells may likewise act as immune sentinels during neonatal
influenza infection, the functions of γδ T cells in influenza-infected infants remain to be
elucidated.
In this study, utilizing a neonatal mouse model of influenza infection, we report
that γδ T cells played an important role in protecting suckling mice against viral
infection. This protection was mediated by augmentation of IL-33 production from the
mucosal compartment that was induced by IL-17A secreted from the responding γδ T
cells. We further showed that this IL-17A-dependent IL-33 production subsequently
generates a local type 2 immune response with increased accumulation of Aregproducing ILC2s and Treg cells in the lung, thus promoting tissue repair and lung
integrity following infection. We also observed correlations between IL-17A, IL-33, and
Areg in nasal washes of human influenza-infected infants. Thus, our findings reveal
important roles for γδ T cells in directing an axis of IL-17A and IL-33 production,
promoting tissue recovery after infection and providing a potential therapeutic target.
Results
γδ T Cells Protect Neonatal Mice Against Influenza Infection by Promoting Tissue
Restoration Independent of Viral Clearance
In influenza-infected adult mice, cytotoxic CD8+ T cells can express death
receptors and produce cytokines and lytic mediators that promote viral clearance (Brincks
et al., 2008; Gruta and Turner, 2014; Price et al., 2000). However, during infancy the
immune system remains developmentally immature, with relatively fewer and less
diverse CD8+ T cells compared to adults (You et al., 2008). In contrast, many γδ T cell
subsets develop fetally and thus are available to respond in neonates. To investigate if γδ
T cells can respond to neonatal influenza infection, we infected 7-day-old wild-type
neonates with A/HKx31 (H3N2) influenza virus. After infection, we observed a
significant accumulation of γδ T cells, characterized by increases in both frequency and
cell number (Figure 3-1A) although there was no change in mock-infected lungs of the
same age (Figure 3-2A, B). EdU (5-ethynyl-2’-deoxyuridine) cell incorporation assays
indicated that the increases in γδ T cells in infected lungs were at least partially due to γδ
T cell proliferation (Figure 3-1B). In order to understand the function of γδ T cells
during influenza infection, we next infected a neonatal cohort of wild-type and γδ T cell
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Figure 3-1. γδ T Cells Protect Neonatal Mice Against Influenza Infection via
Promotion of Lung Homeostasis and Repair, Independent of Viral Clearance.
(A) Representative flow cytometric plots (left), and frequency and number (right) of γδ T
cells in mock- (open circle, n=14) or virus-infected (solid) lungs of wild-type neonates at
1 (n=11) and 2 (n=10) days following intranasal influenza A/x31 virus infection. (B)
Representative flow cytometric plots (left) and summary frequency plot (right) of EdU+
γδ T cells in mock-infected (n=7) and influenza virus-infected (n=7) lungs of wild-type
neonates 2 days after infection. (C and D) Body weight profile (% of original weight) (C)
and survival rate (D) of wild-type (black, n=28) and Tcrd-/- (red, n=26) neonates
following influenza infection. (E) Viral titer (Log10TCID50/ml) of wild-type (black) and
Tcrd-/- (red) neonates assessed by plaque assay at days 0, 3, 5, 7 and 10 after influenza
infection. (F) Measurement of IFN-γ in the total lung homogenates by ELISA of wildtype (black, n=5) and Tcrd-/- (red, n=5) neonates at 7 days after influenza infection. (G)
Gene Set Enrichment Analysis of whole-lung gene expression, ranked by significance (Log10[FDR q-value]), from wild-type (black, n=3) and Tcrd-/- (red, n=3) neonates at 8
days after influenza infection. (H) Representative images of H&E staining of influenza
infected wild-type and Tcrd-/- lungs at 15 days after infection. (I) Summary of
histological analysis from influenza-infected wild-type (black, n=8) and Tcrd-/- (red, n=6)
lungs at 15 days after infection. Data are combined from at least two independent
experiments and shown as mean ± SEM. *p<0.05, **p<0.01, ****p<0.0001, n.s., not
significant.
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Figure 3-2. Gating Strategy and γδ T Cell Prevalence in Mock-Infected Lungs.
(A) Schematic flow cytometric plots of the gating strategies employed during
experiments. (B) Frequency (left) and number (right) of γδ T cells in the lungs of wildtype neonates at days 7, 8, and 9 after birth (equivalent to d0, d1 and d2 of mock
infection). Data are combined from two independent experiments and shown as mean ±
SEM. n.s., not significant.
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receptor-deficient (Tcrd-/-) animals with influenza virus. Compared to Tcrd-/- mice,
relative weight gains were overall significantly larger in wild-type neonates (Figure
3-1C). Wild-type neonates also had a significantly increased survival rate compared to
Tcrd-/- mice (Figure 3-1D), yet the two groups demonstrated no detectable difference in
tissue viral clearance at any time point after infection (Figure 3-1E). Consistent with the
viral titer, loss of γδ T cells did not alter the levels of IFN-γ at Day 7 after infection
(Figure 3-1F). To determine if γδ T cells also play a role in adult influenza infection, we
infected wild-type and Tcrd-/- littermates (8-10 weeks old); no significant differences
were observed in the weight loss profile or survival rate (Figure 3-3A, B) between wildtype and Tcrd-/- adults. These data indicate that in neonatal mice γδ T cells provide
protection against influenza infection without influencing antiviral responses.
To determine if γδ T cells function as immune regulators during infection, we
performed RNA-Seq using total RNA obtained from whole lungs of 3 wild-type and 3
Tcrd-/- neonates 8 days after infection. Gene Set Enrichment Analysis demonstrated
distinct immune pathways in lungs obtained from wild-type and Tcrd-/- mice (Figure
3-1G). Several pathways relevant to tissue development and regeneration were enriched
in wild-type lungs, including the epithelial growth factor receptor (EGFR) pathway (Hall
et al., 2016; Monticelli et al., 2011; Zaiss et al., 2015) and the hedgehog pathway (Hogan
et al., 2014; Sriperumbudur et al., 2017). The absence of γδ T cells was associated with
increased inflammatory pathways, including TNF-α, IL-6, and IL-5. In order to
investigate the downstream effects of these γδ T cell-mediated immune responses on
infected lungs, we performed H&E staining of lung sections. At 15 days after infection,
Tcrd-/- mice were characterized by increased perivascular & interstitial inflammation and
bronchiolar hyperplasia & metaplasia (Figure 3-1H, I), suggesting that γδ T cell
deficiency disrupted lung homeostasis and tissue repair. Collectively, these data indicate
that γδ T cells expand after influenza infection and provide protection to infants by
promoting tissue restoration rather than by enhancing the antiviral response.
γδ T Cells Rapidly Produce IL-17A After Neonatal Influenza Infection
To determine the mechanism by which γδ T cells promoted protection in neonatal
animals, we examined their phenotypes after infection by using CD27 and CD44 surface
marker expression, which distinguish IL-17A- and IFN-γ- producing γδ T cells (Ribot et
al., 2009). We found that γδ T cells were predominantly CD27-CD44hi in virus-infected
neonatal lungs, corresponding to IL-17A production, while they were mainly
CD27+CD44lo (corresponding to IFN-γ production) after mock infection (Figure 3-4A).
After influenza infection, lung γδ T cells also had higher cell surface expression of CCR6
and Sca-1 (Figure 3-4B), consistent with the phenotype of IL-17A-producing γδ T cells.
To confirm the IL-17A-producing phenotype of lung γδ T cells after influenza infection,
we assayed Il17a gene expression using quantitative real-time PCR (qRT-PCR) in sorted
γδ T cells at different points. This analysis indicated that Il17a was upregulated
transiently 1 day after infection. (Figure 3-4C). In concordance with these qRT-PCR
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Figure 3-3
The Role of γδ T Cells in Adult Influenza Infection.
(A and B) Body weight profile (A) and survival rate (B) of wild-type (black, n=15) and
Tcrd-/- (red, n=23) adults after virus infection, normalized to the original weight. Data are
combined from four individual experiments and weight change data are shown as mean ±
SEM. (C) Cell number of adult lung γδ T cells at indicated time point after infection. (D)
Cell number of adult lung IL-17A-producing γδ T cells at indicated time point after
infection. (E) Cell number of adult lung IFN-γ-producing γδ T cells at indicated time
point after infection. (C-E) Data are combined from two individual experiments with
mock infection (n=7), or day 3 (n=10), day 5 (n=5), and day 8 (n=5) after influenza
infection. **p<0.01.
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Figure 3-4. IL-17A-Producing γδ T Cells Rapidly Accumulate and Respond to
Influenza Infection in Neonatal Mice.
(A) Representative flow cytometric plots (left, with CD27 and CD44 expression on xand y-axis, respectively) and summary frequency plot (right) of γδ T cells from mock(open, n=12) and influenza virus- (solid, n=11) infected mice at 2 days following
infection. (B) Representative flow cytometric histogram showing expression of CCR6
(left) and Sca-1 (right) gated on γδ T cells from mock- (open) and virus- (shaded)
infected neonates (2 days after infection). Mean fluorescence intensity are shown in the
upper right corners. (C) Relative expression of Il17a by quantitative real-time PCR in
sort-purified γδ T cells from mock (open, n=6) and virus-infected neonates at 1 (n=6) and
2 (n=6) days following infection. (D) Representative flow cytometric plots of IL-17A
(top) and IFN-γ (bottom) expression in γδ T cells from mock- (left) and virus-infected
(right) neonates at 1 day after infection. (E) Scatter plot showing frequency and number
of IL-17A- (top) and IFN-γ- (bottom) producing γδ T cells from (D). Samples from
mock-infected (n=14) neonates were pooled from animals 1 (n=11) and 2 (n=10) days
after mock infection. (F) Representative flow cytometric plots (left) and summary
frequency plots (right) of γδ TCR expression gated on total IL-17A-producing cells from
mock- (n=14) and virus- (n=11) infected mice at 1 day following infection. Data are
combined from at least 2 independent experiments and presented as mean ± SEM.
**p<0.01, ***p<0.001, ****p<0.0001, n.s., not significant.
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data, the intracellular staining of IL-17A in γδ T cells showed an enhanced frequency and
number of IL-17A-producing γδ T cells in virus-infected lungs, whereas IFN-γ-producing
γδ T cells were not significantly different (Figure 3-4D, E; kinetics shown in Figure
3-5A, B). This transient IL-17A production by γδ T cells did not significantly alter
neutrophil infiltration or accumulation (Figure 3-5C).
γδ T cells can be highly clonotypic in different tissues, especially with respect to
Vγ chain usage (Carding and Egan, 2002). Given the enrichment in CD27- γδ T cells
secreting IL-17A in influenza-infected neonates, we decided to investigate if the T cell
receptor repertoires were altered in cells exhibiting this phenotypes. By utilizing singlecell PCR technology (Dash et al., 2011; Guo et al., 2016; Wang et al., 2012), we
characterized the TRGV family usage by CD27+ or CD27- neonatal γδ T cells (Kashani et
al., 2015) that were mock- or influenza-infected. TRGV family usage varied significantly
between CD27+ and CD27- γδ T cells at different time points after infection (Figure
3-5D and Table 2-1). Furthermore, we observed shifts in the representation of individual
TRGV families in CD27-, but not CD27+, populations. Specifically, TRGV2+ receptors,
which were associated with CD27+ cells at baseline, became enriched in the CD27population.
Upon gating on IL-17A-positive cells, we also found that neonates contained
elevated frequencies of γδTCR+ cells among total IL-17A-producing cells in the early
stages of influenza infection. Furthermore, γδ T cells became the dominant producers of
IL-17A after infection (Figure 3-4F). However, the expression of IL-17A and IFN-γ by
γδ T cells in adult mice showed a distinct pattern from that in neonates: consistent with a
previous study (Crowe et al., 2009), adult γδ T cells produced additional IL-17A at a later
stage of infection (Figure 3-3C, through E). In conjunction, these data from neonates and
adults suggest distinct functionality of γδ T cells across ontogeny, such that neonatal γδ T
cells rapidly secrete and are the primary source of IL-17A in response to influenza
infection.
IL-17A, Primarily Secreted by γδ T Cells, Improves the Survival of InfluenzaInfected Neonates by Enhancing IL-33 Production
IL-17A is the canonical cytokine that regulates type 3 immunity, and its roles in
adult influenza infection are still controversial. Some have suggested that IL-17A can be
beneficial by modulating B cell responses (Wang et al., 2011), whereas others have
proposed that IL-17A signaling may increase immune pathology by promoting neutrophil
infiltration in adults (Crowe et al., 2009). Our data suggest that IL-17A might play a
protective role in neonates because, in comparison to the lungs of virus-infected Tcrd-/neonates, IL-17A (mainly produced by γδ T cells) is increased in wild-type lungs one day
after influenza infection (Figure 3-6A). To test this formally in our experimental model,
we infected Tcrd-/- neonates concomitant with administration of a low-level of
recombinant mouse IL-17A, the dose for which was calculated based on the difference of
lung total IL-17A between wild-type and Tcrd-/- neonates, and monitored the survival
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Figure 3-5. Characterization of γδ T Cells and Neutrophils in Influenza-Infected
Neonatal Lungs.
(A) Frequency (top panel) and cell number (bottom panel) of lung γδ T cells (left), IL17A-producing γδ T cells (middle) and IFN-γ-producing γδ T cells (right), with mock
infection (n=14), or day 1 (n=11), 2 (n=10), 5 (n=13), and 8 (n=7) after infection. (B)
Frequency of IL-17A-producing γδ T cells in mock- (n=10) or influenza- (n=15) infected
neonatal lungs at 1 day after infection, without PMA/Ionomycin stimulation. (C) Percent
(left) and number (right) of neutrophils of wild-type or Tcrd-/- neonates with influenzainfected neonatal lungs at Day 0, 3, 5 and 8 following infections. (D) TRGV family usage
of CD27+ (left) or CD27- (right) γδ T cells estimated by single-cell RT-PCR at mockinfection, 2 days after influenza infection, and 6 days after influenza infection (top to
bottom). TRGV sequence data in the pie chart present Mock-CD27+ (n=11), MockCD27- (n=19), Day2-CD27+ (n=65), Day2-CD27- (n=59), Day6-CD27+ (n=45), and
Day6-CD27- (n=32). Data are combined from at least two independent experiments and
presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s., not
significant.
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Figure 3-6. IL-17A, Predominantly Secreted by γδ T Cells, Improves the Survival
of Influenza-Infected Neonates by Promoting IL-33 Production.
(A) Estimation of IL-17A in whole lung homogenates from mock- (open) or influenza
virus-(solid)- infected wild-type (black) and Tcrd-/- (red) neonates by ELISA at 1 day
after infection. (B) Survival rate of influenza virus-infected Tcrd-/- neonates administered
with low levels of recombinant mouse IL-17A (rmIL-17A, green, n=37, 100pg/mouse) or
PBS control (red, n=19) at the time of infection. (C) Schema outlining wild-type and
Il17a-/- γδ T cell transfers to Tcrd-/- neonates and subsequent infection. (D and E) Body
weight profile (D) and survival rate (E) of influenza-infected Tcrd-/- neonates receiving
wild-type (black, n=15) or Il17a-/- (red, n=13) γδ T cells intranasally or no cell transfer
(grey, n=10). (F) Protein levels of IL-33 assessed by ELISA in influenza virus-infected
wild-type (black, n=15) and Tcrd-/- lungs (red, n=9) at 1 day following infection. (G)
Protein levels of IL-33 detected by ELISA in the lungs of Tcrd-/- neonates that had been
infected with influenza virus and simultaneously treated with either a low level of rmIL17A (green, n=7, 100pg/mouse) or PBS control (red, n=6). Data were collected 1 day
after infection/treatment. (H) Survival rate of influenza virus-infected wild-type (black,
n=20) and Il33-/- neonates (blue, n=17) with intranasal influenza virus infection. (I)
Survival rate of influenza virus-infected Tcrd-/- neonates administered with recombinant
mouse IL-33 (rmIL-33, brown, n=18, 10ng/mouse) or PBS control (red, n=18) at the time
of infection. Data are combined from at least 2 individual experiments.*p<0.05,
**p<0.01, n.s., not significant.
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rate. Low dose IL-17A significantly improved the survival of γδ T cell-deficient mice,
indicating that the IL-17A pathway is protective in the neonatal animals (Figure 3-6B).
In contrast, a high dose of IL-17A administered to infected Tcrd-/- mice was detrimental
to the host (Figure 3-7A), as was a low dose of IL-17A administered to infected wildtype neonates (Figure 3-7B), suggesting that IL-17A fine-tunes the balance between
pathogenicity and protection. In order to determine if IL-17A specifically produced by γδ
T cells is critical for protection against neonatal influenza infection, we isolated γδ T cells
from wild-type or Il17a-/- neonatal lungs, transferred the cells to littermate Tcrd-/neonates intranasally and infected the recipients with influenza virus (Figure 3-6C). The
weight change (Figure 3-6D) and survival rate (Figure 3-6E) profiles suggested that IL17A production by γδ T cells contributed to the protection γδ T cells provide to infected
neonates.
To explore which immune processes may have been disrupted by the loss of IL17A in Tcrd-/- neonates, we next assessed the concentration of a panel of cytokines in
homogenized lungs at day 2 after infection. The majority of cytokines generally
associated with responses to influenza infection, including IFN-γ, IL-2, IL-1β, KC, GMCSF, and IP-10, exhibited no differences between wild-type and Tcrd-/- neonatal lungs at
day 2 after infection, suggesting that traditional innate and Type 1 responses are not
dependent on γδ T cells (Figure 3-7C). In contrast, we found that loss of γδ T cells led to
diminished levels of IL-33 (Figures 3-6F and 3-7D). To confirm this observation, we
again assayed IL-33 to determine if γδ T cell-derived IL-17A was sufficient for inducing
IL-33 in γδ T cell-deficient mice treated with IL-17A. Compared to virus-only controls,
IL-33 levels in whole lung homogenates were elevated in response to low-dose IL-17A
(Figure 3-6G). These data suggest that IL-33 production is upregulated downstream of
IL-17A, which is secreted by γδ T cells in influenza virus-infected mice. In order to
determine if IL-33 production functions as a component of the protection provided by γδ
T cells and IL-17A in influenza-infected neonates, we next infected wild-type and Il33deficient neonates with influenza virus. Il33-/- neonates exhibited increased mortality
compared to wild-type littermates (Figure 3-6H). In addition, and consistent with our IL17A results, the administration of IL-33 also improved the survival of infected Tcrd-/neonate littermates (Figure 3-6I). Therefore, in neonatal mice, γδ T cells are the primary
source of IL-17A, which in turn is necessary for IL-33 production, which itself is
protective in these animals.
IL-17A Promotes IL-33 Production in Mouse Lung Epithelial Cells in Synergy with
Influenza Virus by Elevating STAT3 Phosphorylation
One study recently demonstrated that IL-17A promotes the exacerbation of IL-33induced airway hyperresponsiveness in an allergic asthma model in BALB/c mice
(Mizutani et al., 2014). However, the precise relationship between IL-17A and IL-33
production remains unclear. Although IL-33 can be produced by multiple cell types,
epithelial cells are thought to be the primary source in mouse lungs (Pichery et al., 2012),
and we found sorted lung epithelial cells from wild-type neonates to have the highest Il33
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Figure 3-7. Cytokine Expression and Infected Neonates’ Survival with Cytokine
Administration.
(A) Survival rate of influenza-infected Tcrd-/- neonates administered with of high-dose
of recombinant mouse IL-17A (rmIL-17A, navy, 1000pg/mouse, n=12) or PBS control
(red, n=21) at the time of infection. (B) Survival rate of influenza-infected wild-type
neonates administered with recombinant mouse IL-17A (rmIL-17A, orange,
100pg/mouse, n=10) or PBS control (black, n=8) at the time of infection. (C) Protein
levels of IFN-γ, IL-2, IL-1β, KC, GM-CSF and IP-10 assessed by Milliplex assay and
normalized to the total protein in the lungs of infected wild-type (black, n=5) and Tcrd-/(red, n=5) neonates at day 2 after infection. (D) Protein levels of IL-33 assessed by
ELISA and normalized to the total protein in the lungs of infected wild-type (black) and
Tcrd-/- (red) neonates at indicated time points after infection. Samples are pooled from at
least two independent trials at each time point, and data are presented as mean ± SEM. €
Relative expression results of Il33 gene in endothelial cells, epithelial cells, CD11c+ cells,
and lung fibroblasts isolated from neonatal lungs 2 days after infection (n=3). Data are
combined from at least two independent experiments and presented as mean ± SEM.
*p<0.05, **p<0.01, n.s., not significant.
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gene expression among other lung stromal cell types at day 2 after influenza infection
(Figure 3-7E). We consequently set out to determine if IL-17A could directly induce IL33 production in lung epithelial cells. To test this, we stimulated a mouse lung type 1
epithelial cell line (LET1s) (Rosenberger et al., 2014) in vitro using influenza virus and
recombinant mouse IL-17A (either individually or in combination). After 24 or 48 hours
(hrs) of treatment, the cells in each group were collected to assay IL-33 transcripts and
protein with qRT-PCR and immunoblot, respectively. Quantification of the relative
expression of Il33 mRNA showed that administration of either virus or IL-17A could
enhance IL-33 production in LET1 cells, but the effect of the virus and IL-17A
combination was especially striking (Figure 3-8A). Consistent with these findings,
substantial IL-33 protein was also detected after treatment with both stimuli by
immunoblot (Figure 3-8B). Interestingly, IL-17A alone was more potent than virus alone
in elevating IL-33 mRNA and protein expression.
We next examined the signaling pathways induced by influenza virus and IL-17A
treatment in LET1 cells. Examination of the transcriptional binding sites in the human IL33 promoter (ENCODE data in UCSC genome browser, Build hg19) identified Signal
Transducer and Activator of Transcription 3 (STAT3) as a potential regulator of Il33
transcription, so we performed a Western blot assay to test whether STAT3 was activated
downstream of treatment with either influenza virus or IL-17A. We found that
phosphorylated-STAT3 (pSTAT3) was coordinately upregulated with IL-33 (data not
shown). To confirm the role of pSTAT3 in IL-33 production, we inhibited the
phosphorylation of STAT3 by co-incubating with S3I-201, a well-established small
molecule inhibitor that prevents the dimerization and phosphorylation of STAT3
(Siddiquee et al., 2007). Under the same stimulation conditions as above, we compared
the relative expression levels of Il33 among IL-17A- and/or virus-stimulated LET1 cells
that were co-stimulated with either DMSO or S3I-201 for 48 hrs. The pSTAT3 inhibitor
robustly blocked the upregulation of IL-33 induced by IL-17A, even in the presence of
influenza infection and IL-17A co-treatment (Figure 3-8C). Consistent with these
transcript assays, IL-33 protein abundance was also attenuated after treatment with S3I201 (Figure 3-8D). Thus, our results indicate that IL-17A can directly increase the
production of IL-33 in lung epithelial cells downstream of STAT3 phosphorylation.
Deficiency in γδ T Cells Compromises the Accumulation and Functions of ILC2s
and Treg Cells
ILC2s (Monticelli et al., 2011), Treg cells, and Th cells (Arpaia et al., 2015) have
been reported to play roles in maintaining tissue homeostasis for influenza-infected
adults. Each of these cell types can express the IL-33 receptor (ST2) on their cell surface
and can be recruited to the lungs by IL-33. Compared to Tcrd-/- lungs, we observed more
ILC2s and total Treg cells in wild-type lungs, but comparable amounts of Th cells were
present in both mouse strains at day 5 after infection (Figures 3-9A, B and 3-10A).
ILC2s and Treg cells have both been implicated in the production of Areg, which is
important for tissue repair after influenza infection in adult mice (Arpaia et al., 2015;
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Figure 3-8. IL-17A Elevates IL-33 Production in Murine Lung Epithelial Cells via
STAT3 Phosphorylation.
(A) Relative expression of Il33 mRNA, as assessed by quantitative real-time PCR, in
mouse lung epithelial cells (LET1s) treated with medium (white), A/x31 influenza virus
(blue, 3 MOI), rmIL-17A (green, 50ng/ml), or virus+rmIL-17A (red) at 24hrs and 48hrs
after treatment. Data are shown as mean ± SEM and combined from three separate
experiments that independently showed the same trend. (B) Immunoblot assay of IL-33
protein in stimulated LET1s for the same conditions as in (A) at 48 hrs after stimulation.
(C) Quantitative real-time PCR analysis of Il33 mRNA in LET1 cells treated as in A and
B with and without STAT3 phosphorylation inhibitor S3I-201 (100μM in 0.05% DMSO)
at 48hrs after treatment. Data are shown as mean ± SEM and combined from two separate
experiments that independently showed the same trend. (D) Immunoblot analysis of IL33 and phosphorylated STAT3 (pSTAT3) in the LET1 lysates treated as before (A, B,
and C). Total STAT3 (tSTAT3) and β-actin are also shown. Immunoblots were repeated
twice showing similar results. *p<0.05, ****p<0.0001
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Figure 3-9. Deficiency in γδ T Cells Results in Decreased Accumulation and
Functionality of ILC2s and Treg Cells.
(A) Representative flow cytometric plots (left) and cell number (right) of ILC2s (CD4CD90.2+ Lin- ST2+) in the lungs of infected wild-type (black, n=14) and Tcrd-/- (red,
n=10) neonates at day 5 following infection. (B) Representative flow cytometric plots
(left) and cell number (right) of Treg cells (CD4+ Foxp3+) and Th cells (CD4+ Foxp3-) in
the lungs of infected wild-type (black, n=14) and Tcrd-/- (red, n=10) neonates at day 5
following infection. (C) Representative flow cytometric plots of Areg-producing cells
gated on ILC2s and Treg cells in the lungs of infected wild-type (black, n=14) and Tcrd-/(red, n=10) neonates at 5 days following infection. (D) Frequency (left) and cell number
(right) of Areg-producing ILC2s, Treg cells, and Th cells in the lungs of infected wildtype (black, n=14) and Tcrd-/- (red, n=10) neonates at 5 days after infection. (E)
Representative flow cytometric plots of Areg-producing cells gated on ILC2s and Treg
cells in the lungs of infected wild-type (black, n=8) and Il33-/- (blue, n=6) neonates at 5
days following infection. (F) Frequency (left) and cell number (right) of Areg-producing
ILC2s, Treg cells, and Th cells in the lungs of infected wild-type (black, n=8) and Il33-/(blue, n=6) neonates at 5 days after infection. (G) Relative expression levels of Areg of
ILC2 cells, ST2+CD4+ cells, and ST2-CD4+ cells sorted from wild-type (black, n=5) and
Tcrd-/- (red, n=5) neonatal lungs at 5 days after infection measured by quantitative realtime PCR. (H) Protein levels of Areg in whole-lung lysate from infected wild-type
(black, n=6) and Tcrd-/- (red, n=6) neonates at 5 days after infection. (I) Survival rate of
infected wild-type neonates that were injected intraperitoneally at days 4, 6, and 9 (shown
by arrows) after influenza virus infection with Areg neutralizing antibody (purple, α-Areg
antibody, 2ug/mouse/timepoint, n=21) or isotype control antibody (black, normal goat
IgG control, 2ug/mouse/time point, n=20). Data are combined from at least 2 independent
experiments. *p<0.05, **p<0.01, ***p<0.001, n.s., not significant.
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Figure 3-10. Areg Expression Dynamics During Neonatal Influenza Infection.
(A) Cell number of ILC2s, Treg cells, and Th cells in the lungs of wild-type (black) and
Tcrd-/- (red) influenza-infected neonates at various time point after infection. Data are
combined from at least two individual experiments at each time point and shown as mean
± SEM. (B) Abundance of Areg protein was assessed by ELISA and normalized to the
total protein in the lungs of wild-type (black) and Tcrd-/- (red) influenza-infected neonates
at different time points. Samples are pooled from at least two individual experiments at
each time point, and data are shown as mean ± SEM. (C) Representative flow cytometric
plots of Areg-producing Th cells in wild-type and Tcrd-/- lungs at day 5 following
infection. (D) Frequency of Areg-producing neutrophils in influenza-infected wild-type
(n=7) and Tcrd-/- (n=6) lungs at day 5 after infection. Data are combined from two
individual experiments and shown as mean ± SEM. € Relative gene expression of Il5,
Il10, Gata3, Rorc, Stat3, Tbx21 and Foxp3 in ILC2s, ST2+CD4+ cells and ST2-CD4+ cells
sorted from wild-type (n=5) and Tcrd-/- (n=5) lungs at day 5 after infection. Samples are
pooled from two independent experiments and data are presented as mean ± SEM.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s., not significant.
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Monticelli et al., 2011; Zaiss et al., 2015). The assessment of Areg levels in total wildtype lung homogenates showed that the peak of Areg production was at day 5 after
infection (Figure 3-10B). Thus, we measured the amount of Areg-producing ILC2s, Treg
cells, and Th cells in infected wild-type and Tcrd-/- neonates at this time point. We found
higher frequencies and numbers of Areg-producing ILC2s and Treg cells in wild-type,
infected lungs compared to those from TCRδ-deficient mice (Figure 3-9C, D). In
contrast, Th cell responses were equivalent between the two groups at day 5 after
infection (Figures 3-9D and 3-10C). In addition, neutrophils accumulating in the
infected lungs rarely produced Areg (Figure 3-10D). Consistent with the importance of
IL-33 in regulating type 2 responses, the frequency and number of Areg-producing ILC2s
were also higher in wild-type neonates compared to Il33-/- animals (Figure 3-9E, F). In
order to characterize the Areg-producing cells more thoroughly, we isolated ILC2s,
ST2+CD4+ cells, and ST2-CD4+ cells from wild-type and Tcrd-/- neonatal lungs at day 5
after infection and performed qRT-PCR assays to measure gene expression of multiple
signature genes. Although many factors remained unchanged, cells from wild-type mice
exhibited higher levels of Areg and Il10, while cells from Tcrd-/- had elevations in type 2
response genes, including Il5 and Gata3 (Figures 3-9G and 3-10E, F). The consistently
lower Areg expression in cells from Tcrd-/- mice strongly suggests that the deficiency in
γδ T cells compromises tissue repair after infection (Figure 3-9G).
In order to investigate the importance of Areg in the neonatal influenza model, we
next assessed the levels of Areg by ELISA. The overall abundance of Areg protein was
lower in Tcrd-/- whole-lungs relative to wild-type lungs (Figure 3-9H), and this
deficiency is likely implicated in the reduced survival rate observed in Tcrd-/- mice after
infection (Figure 3-1D). Based on the kinetics of Areg production (Figure 3-10B), we
also delivered Areg neutralizing antibody or isotype control antibody intraperitoneally to
wild-type mice on Days 4, 6, and 9 after infection. After monitoring the survival of these
treated mice, we found that Areg is protective during neonatal influenza infection
(Figure 3-9I) in wild-type animals. Taken together, these results suggest that neonatal γδ
T cells benefit neonatal mice during influenza infection specifically by mediating Areg
production via ILC2s and Treg cells.
IL-17A, IL-33, and Areg Are Correlated with Each Other and with Improved
Outcomes in Influenza-Infected Human Children
To determine whether the findings in our neonatal influenza mouse model were
translatable to humans, we assessed the abundance of IL-17A, IL-33, and Areg in nasal
aspirates obtained from children and infants with community-acquired influenza
infection. We found that IL-33 levels were significantly and positively correlated with
IL-17A levels in the airways of influenza-infected subjects (Figure 3-11A). However,
IL-33 was not correlated with IFN-γ (Figure 3-11B), suggesting that IL-33 production is
not controlled by IFN-γ in this context and that all cytokine levels were not generally
correlated. We also found a positive correlation between IL-33 and Areg (Figure 3-11C).
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Figure 3-11. The IL-17A/IL-33/Areg Cascade in Influenza-Infected Children Is
Associated with Robust Disease Outcome.
(A-C) Correlation between concentrations of human IL-17A and IL-33 (A), IFN-γ and
IL-33 (B) and IL-33 and Areg protein levels (C) in the nasal aspirates of influenzainfected children (< 8 years old, n=51). (D) Concentration of IL-17A at Day 0 after
enrollment in the nasal aspirates of children with mild (black, n=11) and severe (red,
n=12) influenza disease outcomes. (E) Concentration of IFN-γ at Day 0 after enrollment
in the nasal aspirates of children with mild (black, n=11) and severe (red, n=12) disease
outcomes. Data are presented as mean ± SEM, and in each case cytokine values (pg/ml)
were log10 transformed for visualization only. *p<0.05.
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However, IFN-γ and Areg (Figure 3-12A) were also correlated, possibly indicating the
existence of independent pathways associated with Areg-production in human infection,
or a non-mechanistic correlation between IFN-γ and Areg kinetics.
In searching for correlates of disease outcome, we found that IL-17A
concentrations at diagnosis (within 96 hours of symptom onset) in nasal aspirates
predicted the severity of influenza illness in infants and children, as those with mild
disease outcomes had significantly higher levels of IL-17A than those with severe
outcomes (Figure 3-11D). In contrast, IFN-γ was neither correlated with IL-17A (Figure
3-12B) nor associated with disease severity (Figure 3-11E).
To confirm our observation in mice that IL-17A can directly induce IL-33
production by lung epithelial cells, we stimulated cells from a human lung epithelial cell
line (A549) with virus and/or recombinant human IL-17A together with either DMSO or
the STAT3 inhibitor S3I-201 (as above). qRT-PCR analysis of these treatments indicated
that, as in mice, human IL-17A can enhance the gene expression of IL33 in lung
epithelial cells in a STAT3 phosphorylation-dependent manner during influenza infection
(Figure 3-12C). In summary, IL-17A (rather than IFN-γ) is positively associated with the
IL-33-Areg axis and potentially influences the disease outcomes in children with
influenza infections.
Discussion
In comparison to older children and young adults, infant influenza infections are
associated with higher rates of hospitalization and mortality. In the human FLU09 cohort,
we previously reported that viral clearance was not impaired in infants compared to other
demographic groups, and yet disease severity was increased (Oshansky et al., 2014).
Intriguingly, previous reports have also shown that neonates cannot mount robust type 1
immune responses, as revealed by the insufficient magnitude and function of neonatal
CD8+ T cells (You et al., 2008). Instead, type 2 immune responses are more dominant in
the neonatal immune system (Adkins et al., 2004; Dowling and Levy, 2014; Garcia et al.,
2000), perhaps as a mechanism limiting potential inflammatory damage. As a result of
the variations in the immune system evident throughout ontogeny, the parameters that
determine mild or severe outcomes after influenza infection likely differ between infants
and adults.
During the development of the immune system, γδ T cells develop and migrate to
mucosal organs prior to αβ T cells, suggesting that the former may play a critical role in
immune competence in neonates (Chien et al., 2014; Hayday, 2000; Vantourout and
Hayday, 2013). Here, we confirmed that notion by defining a significant role for γδ T
cells in maintaining lung homeostasis and tissue integrity during neonatal influenza
infection.
The primary function of γδ T cells in this model of influenza infection appears to
be the rapid production of IL-17A to initiate a cascade of type 2 and tissue repair F 3-12
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Figure 3-12. Correlation of IFN-γ - Areg and IFN-γ - IL-17A in Children, and IL33
Gene Expression in Stimulated A549 Cells.
(A) Correlation between concentration of human IFN-γ (x-axis) and Areg (y-axis) in
influenza-infected children (n=51). Cytokine values (pg/ml) were log10 transformed for
visualization. (B) Correlation between concentration of human IFN-γ (x-axis) and IL17A (y-axis) in influenza-infected children (n=51). Cytokine values (pg/ml) were log10
transformed for visualization. (C) Relative expression of IL33 transcripts in human lung
epithelial cells (A549) treated with DMSO or the pSTAT3 inhibitor and stimulated for 48
hours with medium, influenza virus, rmIL-17A, or the virus-rmIL-17A combination.
Data are shown as mean ± SEM and combined from three separate experiments that
independently showed the same trend. *p<0.05, **p<0.01.
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responses, which were characterized by the induction of IL-33, the recruitment of ILC2s
and Treg cells, and the production of amphiregulin. However, the ligands for γδ T cell
activation in this system are undetermined. This unconventional role for IL-17A diverges
significantly from its better characterized contributions to type 3 immunity, for instance
in responses to lung infections by bacteria such as Staphylococcus aureus (Cheng et al.,
2012) and Mycobacterium tuberculosis (Lockhart et al., 2006) . Thus far, little has been
discovered about the potential role of IL-17A in type 2 immunity, which predominates
during allergic reactions and helminth infections rather than bacterial infections
(Spellberg and Edwards, 2001). One study has suggested IL-17A-producing γδ T cells
can modulate regulatory T cell homeostasis and thermogenesis in adipose tissues by
inducing IL-33 production (Kohlgruber et al., 2018). Another study has reported an
exacerbation of IL-33 production after IL-17A administration, but this was in a model of
allergic asthma, where the effects of IL-17A were primarily pathological (Mizutani et al.,
2014). Although IL-17A and influenza virus both induce robust IL-33 production, IL17A is more potent than virus in upregulating IL-33 expression in lung epithelial cells
through STAT3 phosphorylation. Recent studies also found that IL-17A can promote
tumor growth (Wang et al., 2009) and angiogenesis (Pan et al., 2015) via STAT3
phosphorylation, suggesting that this may be a common potential target for IL-17A
signaling, with effects on tissue repair and remodeling. In contrast, canonical IL-17A
signaling proceeds through the nuclear factor-κB (NF-κB) pathway mediated by ACT1
(Gaffen, 2009), which results in the activation of the type 3 immune response
traditionally associated with IL-17A. In LET1 cells we found that NF-κB activation (data
not shown) was dispensable for IL-33 induction.
To confirm the specific role of IL-17A produced by γδ T cells in protection, we
performed a γδ T cell-transfer experiment from IL-17A wild-type or deficient mice. Our
results showed a significant difference in the survival between infected Tcrd-/- neonates
receiving wild-type γδ T cells and those receiving Il17a-/- γδ T cells. However, we also
observed a delayed, but not significantly different, survival among Tcrd-/- neonates with
Il17a-/- γδ T cells, compared to Tcrd-/- neonates receiving a PBS control. Thus, we
speculate there may be some small additional potential IL-17A-independent effects of
neonatal γδ T cells. Transfer of γδ T cells into mice lacking both IL-33 and γδ T cells
would confirm the requirement for an intact IL-33 pathway downstream of γδ T cell
activity and will be the subject of future experiments in the lab.
Given the important role of type 2 immunity in mediating allergy and asthma, as
well as the epidemiological linkages between infant infections and future development of
these diseases, it seems possible that this IL-17A-IL-33 pathway may be a key link
between early infection and atopy. One hypothesis for why this pathway may be more
active or essential in neonates than in adults, where the effects of IL-17A appear minimal,
is the significantly smaller lung volumes in the very young. Lung damage resulting from
infection can, as a proportion of total lung volume, generate a greater impact on lung
efficiency. Thus, robust induction of type 2 immunity and its associated tissue repair
function may be necessary to maintain the capacity of the infant lung, albeit at the cost of
an increased risk of subsequent pathologies.
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Of particular interest, we observed that IL-17A, instead of IFN-γ, is positively
correlated with IL-33 in nasal aspirate samples from children with naturally-acquired
influenza infection. This correlation also extends to IL-33 and Areg in these samples,
consistent with the findings in our mouse model demonstrating an early regulatory role of
IL-17A for the subsequent immune response to neonatal influenza infection.
Interestingly, this is thus far the only protective association with an increased
cytokine concentration that we have observed in this cohort. In contrast, type 1 immune
responses were not associated with IL-33. These data indicate the novel IL-17A-IL-33Areg axis may serve as a potential therapeutic target during infant influenza infection;
further study of these markers across additional human cohorts will be important not only
for verifying the importance of this axis in infant influenza infection, but also for fully
elucidating the particular conditions underlying this aspect of γδ T cell function in
humans in general.
In conclusion, our findings provide evidence that IL-17A, secreted by γδ T cells,
has a critical function in protecting infants during influenza infection. IL-17A-producing
γδ T cells may provide this protection by inducing IL-33 secretion and type 2 immune
responses which, in turn promote tissue homeostasis and integrity.
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CHAPTER 4. RAPID CLONING, EXPRESSION, AND FUNCTIONAL
CHARACTERIZATION OF PAIRED αβ AND γδ T-CELL RECEPTOR CHAINS
FROM SINGLE-CELL ANALYSIS5
Introduction
T cells play a vital role in the control of viral infections and tumors. T cells are
activated by antigen presenting cells via interactions between peptide-major
histocompatibility complex (pMHC) and TCRs. This interaction can induce proliferation
and the development of effector functions, including cytokine production and cytotoxic
activity. T cells can also infiltrate infected or transformed tissues, e.g. as tumorinfiltrating lymphocytes (TILs), to perform these effector functions (Restifo et al., 2012;
Rosenberg and Restifo, 2015). However, in some chronic viral infections and tumors,
responding effector T cells progressively get exhausted and become dysfunctional
(Baitsch et al., 2011; Wherry and Kurachi, 2015; Wherry et al., 2007) In addition, control
of tumors and/or infection may require large numbers of highly reactive lymphocytes that
cannot be achieved due to normal tolerance mechanisms. One effective method to
overcome this barrier is the use of therapeutic adoptive transfer of lymphocytes (Besser et
al., 2013; Klaver et al., 2015; Rosenberg and Restifo, 2015)
Adoptive transfer of lymphocytes such as in vitro expanded or TCR-engineered
antigen specific T cells has been successfully used to control viruses and tumors in
patients (Besser et al., 2013; Chapuis et al., 2012; Hinrichs et al., 2009; Kershaw et al.,
2006; Lamers et al., 2011). In vitro expansion of viral or tumor-specific T cells require
significant time to prepare and the targets are not usually fully characterized.
Lymphocytes expressing engineered TCRs and chimeric antigen receptors (CAR) target
specific antigens, with CARs recognizing surface antigens through immunoglobulin-type
interactions (Han et al., 2013; Ramos and Dotti, 2011) and TCRs recognizing tumorassociated pMHC complexes. CAR therapy directed against surface antigens requires a
tumor-associated antigen that can be universally targeted (even on healthy, non-tumor
tissue) without significant toxicity. Tumor-specific antigens that are targeted by TCRs
represent an attractive alternative that can provide greater specificity and reduce nontumor associated toxicities (Schmitt et al., 2009; Stauss et al., 2015; Varela-Rohena et al.,
2008). Additionally, engineered T cells expressing high-affinity antigen receptors can be
conditioned to overcome immune tolerance, which has been a major limitation for
immunotherapy (Schmitt et al., 2009, 2015; Varela-Rohena et al., 2008) Apart from the
clinical applications, a robust system for the cloning and expression of TCRs is a
valuable tool for the investigation of TCR structure and functions (Birnbaum et al., 2014;
Luoma et al., 2013; Vavassori et al., 2013).
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S., Dallas M.H., Thomas P.G. (2016). Rapid cloning, expression, and functional characterization of paired
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Techniques to rapidly profile and clone antigen-specific TCRs have improved and
shortened the process of TCR-engineered immunotherapy (Kobayashi et al., 2013;
Linnemann et al., 2013). These approaches are useful contributions to the field and are
able to handle large cell inputs very effectively. However, for certain applications, the
reported methods still have some limitations. First, approaches that rely on deep
sequencing and cloning of bulk sorted cells can still be limited by target cell numbers. In
contrast, single cell approaches can utilize input sizes starting with a single cell but are
less efficient at dealing with high cell number inputs (greater than 10,000 cells). As a
result, single cell methods are best directed at defined samples such as antigen-specific
responses or tissue-associated infiltrating cells. Second, for bulk sorting, pairing of TCR
chains requires algorithmic imputation, which can have difficulty dealing with cells
expressing two distinct TCR chains of one type (e.g. two TCRα chains), which are quite
common. A recently reported algorithm has addressed this concern and efficiently pairs
bulk processed TCRs, using barcoded pools of cells (Howie et al., 2015). This method,
though, requires relatively large inputs to successfully pair and would likely not be
appropriate for very small sample sizes as might be obtained from tissue biopsies or
tetramer sorting of small populations.
Third, while currently described methods are able to generate full length receptors
either by synthesis or by 5’ RACE-associated approaches at the single cell level, these
methods often are reported to require expansion of the isolated cells prior to TCR
isolation. Lastly, the majority of antiviral and antitumor adoptive therapy has focused on
αβ T cell clones due to their exquisite antigen specificity. However, γδ T cells have also
been shown to mediate antiviral and antitumor effects and are novel candidates for
therapeutic development (Perko et al., 2015; Silva-Santos et al., 2015). To date, there is
little research about profiling and utilizing the TCRγδ repertoire for therapeutic purposes,
and as such applying γδ T cells for immunotherapeutic applications may be a promising
future approach in conjunction with traditional TCRαβ techniques. Therefore, it is
important to establish a system to define the repertoire and functional activity for γδ T
cells. Additionally, improving efficiencies for cloning αβ TCRs from single cells may
have complementary uses in the lab and in the clinic.
To overcome these limitations, we developed a rapid cloning and expression
system for specific TCRs. In conjunction with single cell multiplex PCR techniques for
TCRαβ or TCRγδ profiling (Dash et al., 2011; Wang et al., 2012), and Gibson
Assembly® cloning of synthesized DNA, we were able to rapidly sequence and clone
specific TCRs in a retroviral expression vector. Moreover, by generating V regionspecific libraries, this protocol can be significantly accelerated by only requiring the
substitution of the CDR3 region (Bryksin and Matsumura, 2010), resulting in cloned
TCRs in appropriate expression vectors in as little as five days after cell isolation with
highly robust, inexpensive methods. Thus, this protocol provides an efficient and
relatively high-throughput means for TCR engineering for therapeutic or research
applications.
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Results
Paired TCRγδ Analysis of Human PBMC Samples at the Single Cell Level
Following on our previously reported single cell PCR protocols for TCRαβ (Dash
et al., 2011; Wang et al., 2012), we developed a similar strategy to characterize the paired
TCRγδ repertoire in humans (Figure 4-1A). The primers were designed for all nonpseudogene TRGV and TRDV regions along with antisense primers for their respective
constant regions. Two sets of primers (external and internal) were designed in order to
perform a nested PCR (Tables 2-2 and 2-3). The PCR products were examined by
agarose gel electrophoresis before sequencing (Figure 4-1B). The average success rate
for obtaining paired CDR3γ and CDR3δ sequences at the single cell level from human
PBMC samples is 71.25±18.75%. The TRGV/TRDV family usage was determined from
the multiplex PCR products (Figure 4-1C). On average, 20% of the sequences from our
analysis of 14 human PBMCs were TRGV9/TRDV2. This technique along with the
established mouse and human αβ single cell multiplex PCR offers a rapid method
(turnaround time ~3 days per 160 cells) for characterizing paired TCRγδ chains at the
single cell level. The data of paired TRGV/TRDV family usage percentage in each
human sample are shown in Table 4-1.
Establishment of Human TCRαβ and TCRγδ Retroviral Expression Clones
Many of the downstream applications of paired TCRαβ or TCRγδ sequence
analysis require cloning and expression of the antigen specific receptors for
immunological studies such as structural and functional characterization, biochemical
characterization, epitope identification, and gene therapy (Uldrich et al., 2013; Vavassori
et al., 2013; Yoshio Ogawa, 2013). Thus, we sought to develop a rapid cloning method
to improve on conventional restriction enzyme-mediated ligation techniques, which can
be cumbersome and time consuming. In addition, use of restriction enzymes for cloning
becomes problematic because of the potential for restriction sites to appear in some
variable regions and the non-germline CDR3 sequences of the TCR chains. The vector
that we chose for TCR expression is pMICherry, which has been successfully used to
construct TCR clones for the generation of retrogenic mice (Bettini et al., 2013; Holst et
al., 2006). A schematic diagram of the cloned TCR chains in the pMICherry vector is
shown in Figure 4-2A.
To clone full length TCR chains, as a proof of principle, we chose a
TRGV9/TRDV2 clone to demonstrate the feasibility of our cloning system, since the
TRGV9/TRDV2 clonotype is dominant in the TCRγδ repertoire analysis from human
PBMCs (Figure 4-1C). Similarly, a human TCRαβ pair was chosen derived from an
influenza-specific CD8 T cell from an infected individual (unpublished data). Using the
IMGT-reported human TRGV, TRDV, TRGC, and TRDC sequences for TCRγδ or
human TRAV, TRBV, TRAC and TRBC sequences for TCRαβ and our single cell
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Figure 4-1. Unbiased Single-Cell Amplification of Paired TCR CDR3 Regions.
(A) Overview of the multiplex PCR protocol to amplify and sequence paired TCR CDR3
α/γ and CDR3 β/δ. After sorting single human αβ or γδ T cells into a 96-well plate,
reverse transcription is performed to obtain single-cell cDNA. Taking human γδ T cells
as an example, a first round of PCR is performed by using an external primer mixture of
9 TRGV and 8 TRDV sense and single TRGC and TRDC antisense primers following
RT-PCR. The first-round PCR products are subjected to two separate second-round PCRs
using a corresponding internal primers mix (9 sense TRGV, single antisense TRGC, and
8 sense TRDV, single antisense TRDC, respectively). The timeline of this process is
shown on the left. (B) An agarose gel electrophoresis image of TCR segments containing
CDR3γ and CDR3δ is shown. Paired CDR3γ and CDR3δ products from the same cell
were loaded in adjacent lanes. Negative control PCR reactions are shown in the boxed
region and in the ladder lane, a 500bp label is shown.(C) Paired TRGV/TRDV usage is
determined by multiplex PCR and sequencing (n=14 human apheresis rings). The
percentage of different TRGV/TRDV usage in each sample was assessed (mean±SEM).
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Table 4-1.

TRGV/TRDV Repertoire Among 14 Human Samples.

TRGV/TRDV Usage

Mean

Standard Deviation

Standard Error

TRGV9/TRDV2

20.06

16.11

4.306

TRGV4/TRDV1

12.71

15

4.008

TRGV8/TRDV1

8.714

10.63

2.842

TRGV9/TRDV3

8.357

21.25

5.68

TRGV2/TRDV1

7.836

14.61

3.906

TRGV1/TRDV2

4.643

13.51

3.61

TRGV3/TRDV3

4.35

13.09

3.498

TRGV9/TRDV1

4.279

8.702

2.326

TRGV4/TRDV3

4.071

9.059

2.421

TRGV3/TRDV1

4.029

5.646

1.509

TRGV2/TRDV3

3.071

8.801

2.352

TRGV5/TRDV3

2.643

6.744

1.802

TRGV8/TRDV2

1.971

5.388

1.44

TRGV5/TRDV1

1.871

3.633

0.9711

TRGV2/TRDV2

1.871

3.633

0.9711

TRGV8/TRDV3

1.643

4.557

1.218

TRGV2/TRDV5/TRAV29

1.492

4.706

1.305

TRGV3/TRDV2

1.279

2.922

0.7808

TRGV10/TRDV1

1.071

2.31

0.6175

TRGV9/TRDV8/TRAV38

0.3571

1.336

0.3571

TRGV4/TRDV2

0.1857

0.6949

0.1857

TRGV9/TRDV5/TRAV29

0.1714

0.6414

0.1714
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Figure 4-2. Rapid Cloning and Expression of Human TCRαβ or TCRγδ in a
Retroviral Vector.
(A) Schematic diagram of TCR cloning using gBlock® synthesized DNA fragments and a
linearized retroviral vector (pMICherry) is shown. Family specific TRGV and TRDV full
length TCR chains were synthesized with a 15-20bp overlap sequence (purple) in the 2A
region (pink). Together with a linearized pMICherry expression vector, a three-way
ligation is performed by using Gibson Assembly® Cloning. The timeline of this process is
presented on the left. (B) Expression of TCR constructs in the Jurkat 76 TCRα-β- cell
line. The vectors with human TRGV9/TRDV2 TCR genes (top panel) and human
influenza-specific TCRαβ genes (bottom panel) were co-transfected with the human CD3
construct into the Jurkat 76 TCRα-β- cell line. The flow cytometry results of transfected
cells are shown.
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CDR3γ and δ or CDR3α and β sequence data we constructed full length TCRγ and δ
chains and TCRα and β chains joined by the 2A “self-cleaving” site in silico. 2A
oligopeptides can interact with the ribosomal exit tunnel to terminate sequence translation
at the final codon (Pro) of the 2A sequence, and reinitiate translation of the following
sequence (Sharma et al., 2012). Recently, multi-cistronic 2A based retroviral vectors
have been widely used for TCR:CD3 structural and functional studies (Bartok et al.,
2010; Bettini et al., 2012, 2013; Day et al., 2011; Holst et al., 2006; Szymczak et al.,
2004). The entire sequence of TCRγ-2A-TCRδ along with an 25bp overhang
complementary to the ends of the linearized pMICherry vector were synthesized in two
fragments of approximately 1kb each as gBlock® DNA fragments (IDT) with an internal
25bp overlap in the 2A segment. By using Gibson Assembly® Master Mix, we ligated
the two gBlocks spanning the TCRγ-2A-TCRδ with the linearized vector in a three-way
ligation. The process of cloning is shown in Figure 4-2A. After this cloning procedure,
an average of 70.9% of the colonies picked after transformation were entirely matched
with target sequences. The others contained either point mutations resulting from the
cloning process or no inserts. To date, we have cloned more than 30 different TCR
constructs by using this system, including, mouse and human TCR αβ and TCRγδ. The
cloning system is highly reproducible and we have succeeded in generating clones in all
attempts.
To test the functionality of the TCR clones that were made following the method
described in Figure 4-2A, we transfected the human TRGV9/TRDV2 construct into the
Jurkat 76 TCRα-β- cell line and checked for the cell surface expression by anti-TCRγδ
and anti-CD3 antibody staining and flow cytometry. Although Jurkat cells have
endogenous CD3, the expression of TCRγδ was not robust. Since γδ T cells do not
develop in CD3-deficient mice and patients (Siegers et al., 2007), we cloned the human
CD3 complex into an MSCV vector (pMIAmetrine) and co-transfected it with our human
TCR constructs. mCherry and ametrine are the reporter genes in the pMICherry vector
with human TCR genes and the pMIAmetrine vector with human CD3 genes,
respectively. We demonstrated that co-transfection of the human CD3 construct with the
human TCRγδ and αβ chains can improve the surface expression level of TCR in a Jurkat
cell line (Figure 4-3A through C). 3.76% of cells were double positive for mCherry and
ametrine, and 19.5% of double-positive cells were TCRγδ and CD3 positive, which
proved the functionality of our cloning and expression platform (top panel, Figure 4-2B).
We analyzed the expression of the influenza virus-specific TCRαβ by staining the
transfected cells with APC-conjugated influenza-M1 tetramer (HLA-A*0201,
GILGFVFTL) and CD3 antibody. The FACS plot shows 5.03% of transfected cells were
double positive for mCherry and ametrine, 16.1% of which were positive for tetramer
staining (bottom panel, Figure 4-2B).
Effective TCR Activation Reporting by Nur77-GFP Jurkat 76 TCRα-β- Cells
An important application of TCR cloning and expression is to screen molecules
that can activate or inhibit TCR signaling. Thus far, the common methods to detect TCR
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Figure 4-3. Co-Transfection of Human CD3 Can Improve the Expression of
Human TCR Constructs.
(A-B) Comparison of single transfection of human TCR constructs and co-transfection of
human TCR constructs and human CD3. (C) Quantification of mCherry/ametrine and
TCR/CD3 expression is shown. Statistical differences were determined by One-way
ANOVA; p < 0.05 was considered statistically significant. Data are mean ± SEM of two
independent experiments***p < 0.001, ****p < 0.0001.
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activation are using ELISA to detect cytokines (e.g. IFN-γ) in the cell culture medium
(Kobayashi et al., 2013; Linnemann et al., 2013), intracellular staining to report cytokine
production by flow cytometry, or qRT-PCR to quantify the mRNA expression of
cytokines, which are time-consuming, labor-intensive, and expensive. Hence, we
established a TCR activation reporter cell line, Nur77-GFP Jurkat 76 TCRα-β- (NJ76
cells). The Nur77-GFP reporting system has been demonstrated to reflect specific TCR
signal strength by GFP expression(Au-Yeung et al., 2014; Gao et al., 2014; Moran et al.,
2011). Here, we established the NJ76 cell line by stably transducing Nur77-GFP BAC
DNA into Jurkat 76 TCRα-β- cells.
To test the functionality of NJ76 cells in reporting TCR activation, we transfected
NJ76 cells with a murine KbPB1703-specific TCR αβ derived from influenza-infected
mice along with mouse CD3. The KbPB1703+TCRαβ+ NJ76 cells (PB1-NJ76) were
incubated with mouse splenocytes, the influenza PB1703 peptide, splenocytes and peptide,
or mouse α-CD3/human α-CD28 as a positive control for 4 hours and GFP expression in
transfected NJ76 cells was detected by flow cytometry (Figure 4-4A). The quantification
of GFP levels is shown in Figure 4-4B. The results show that PB1-NJ76 cells can
robustly express GFP after specific peptide stimulation (PB1) with antigen-presenting
cells. The gating strategy for GFP detection is shown in Figure 4-5.
This TCR-activation reporting system has also been tested for TCRγδ signaling.
Zoledronic acid (Zometa, Novartis, Basel, Switzerland) is an aminobisphosphonate that
has demonstrated antitumor effects via inhibition of tumor growth and angiogenesis and
induction of malignant cell apoptosis in humans (Gnant and Clézardin, 2012; Peng et al.,
2007). In addition, zoledronic acid can specifically stimulate and expand human
TRGV9/TRDV2 cells (Di Carlo et al., 2013; Goto et al., 2013; Sprini et al., 2014; Wada
et al., 2014). Since it can result in the accumulation of upstream metabolites in the
mevalonate pathway , e.g. IPP, which induce the expansion of γδ T cells in vitro and in
vivo, zoledronic acid pre-treatment can increase the cytolysis of some cancer cell lines by
γδ T cells (Suzuki et al., 2010). After transfection of the human TRGV9/TRDV2 vector
and human CD3 vector into NJ76 cells, we pulsed the transfected TRGV9/TRDV2-NJ76
cells with 50μg/ml of zoledronic acid for 3 hours, and washed and incubated the cells at
37°C for 12h. We quantified the GFP expression level in transfected TRGV9/TRDV2NJ76 cells and control cells by flow cytometry. The Nur77-GFP expression level is
shown in Figure 4-4C, top. The transfected TRGV9/TRDV2-NJ76 cells showed a
significantly higher level of GFP expression, which demonstrates that zoledronic acid can
trigger γδ TCR signaling for the stimulation and expansion of γδ T cells. The fold change
of GFP expression over time in stimulated TRGV9/TRDV2-NJ76 cells (Red line) and
non-stimulated TRGV9/TRDV2-NJ76 (Black line) is shown in Figure 4-4C, bottom.
Rapid TCR Cloning by CDR3 Substitution Using Overlap Extension PCR and TCR
Library
For TCRs, the only hypervariable regions are the CDR3 regions. Thus, cloning
full length TCRs de novo for each application may expend unnecessary resources. To
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Figure 4-4. Nur77-GFP Jurkat 76 TCRα-β- Cells Can Report the TCR Signaling
Activation.
(A) Following co-transfection of a murine KbPB1703-specific TCR αβ derived from
influenza-infected mice and a mouse CD3 construct, the KbPB1703+TCRαβ+ NJ76 cells
(PB1-NJ76) were stimulated either with influenza PB1703 peptide alone or PB1703
peptide-pulsed splenotytes for 4 hrs.Anti-mouse CD3/α-human CD28 stimulation was
also done as a positive control. The GFP expression was assessed by flow cytometry. (B)
The quantification of GFP expression in PB1-NJ76 cells is shown. Statistical differences
were determined by One-way ANOVA. (C) The transfected human TRGV9/TRDV2NJ76 cells were pulsed with zoledronic acid (50ug/ml) for 3h at 37°C, and washed and
incubated at 37°C for 12h. The GFP expression of stimulated NJ76 cells (Grey line), nonstimulated TRGV9/TRDV2-NJ76 (Black line) and stimulated TRGV9/TRDV2-NJ76
cells (Red line) is shown (top panel). Fold change of GFP expression in stimulated
TRGV9/TRDV2-NJ76 cells (Red line) compared to non-stimulated TRGV9/TRDV2NJ76 (Black line) is shown as a time course (bottom panel). Statistical differences were
determined by Two-way ANOVA; p < 0.05 was considered statistically significant. Data
are mean ± SEM of two independent experiments. **p < 0.01, ***p < 0.001, ****p <
0.0001, n.s. non-significant.
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Figure 4-5. Gating Strategy of TCR-Transfected-NJ76 Cells in Flow Cytometry.
The data of TCR-transfected-NJ76 cells after stimulation in Figure 3 were analyzed by
applying the gating strategy to all the samples. The gating strategy is “Single cell gate –
Lymphocytes gate – Singlets gate – mCherry+Ametrine+ gate – TCR+CD3+ gate –
GFP+ gate”.
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improve on this, we have generated a library of potential TRGV and TRDV “backbone”
combinations that only require the swapping of individual CDR3 regions directly from
PCR products. For example, in TRGV9/TRDV2 cells from PBMCs of healthy donors,
the CDR3s of both γ and δ chains were found to be highly diverse (Table 4-2). To
rapidly generate a library of diverse TRGV/TRDV clones, we designed DNA linkers,
whose ends overlap with the TRGC and TRDV in our single cell PCR products. These
DNA linkers contain the TRGC region, 2A and one of the TRDV regions, as is shown in
Table 2-6. By overlap PCR with the single cell PCR products, DNA linkers, TRGV
sense primers, and TRDC antisense primers, we can connect any pair of TCRγδ together.
Next, we use these first-step PCR products as a mega primer with the appropriate clone
from our library as a template for the second-step overlap extension PCR. By using this
substitution method, we have successfully cloned different γδ TCRs with matched
CDR3s from our human single cell PCR products. In principle, the same approach could
be used with αβ TCRs, although the clone library would be larger. As an estimate, this
CDR3 substitution approach can shorten the cloning process to within 5 days (Figure
4-6).
Discussion
Here we report several useful techniques for the analysis of TCR biology,
including a single-cell based protocol for γδ TCR amplification, a rapid protocol for TCR
cloning and expression, and a novel platform for functional characterization of TCR
clones. Our system provides an accurate and efficient method to approach rapid cloning
at the single cell level, which can improve the development of multiple applications,
including TCR-mediated immunotherapy.
The most prominent recent immunotherapy approaches involve T cell checkpoint
blockade inhibitors(Pardoll, 2012). However, these therapies depend on the presence of
significant numbers of anti-tumor T cells. The ex vivo expansion of tumor infiltrating
lymphocytes has also been successful, but is time consuming (Dudley et al., 2003). Our
protocol could significantly accelerate the amount of time needed to generate large
numbers of anti-tumor T cells, by allowing the efficient transduction of identified antitumor receptors. The key to the application of this form of directed T cell immunotherapy
is the rapid and accurate isolation and cloning of paired TCRs. Thus far, various methods
have been developed for the cloning of TCR genes by traditional PCR, but the acquisition
and expression of TCRs is often labor-intensive, time-consuming, expensive, and nonspecific. The system we have described provides efficient acquisition of TCR gene
products for cloning based on single cell isolation, with an amplification success rate of
isolated paired single cell TCRγ and TCRδ CDR3 products of 71.25±18.75% based on
total sorted single cells in each sample. We have also developed a platform for screening
TCR activation after cloning. By inserting the Nur77 reporter into a Jurkat 76 TCRα-βcell line, we have generated a useful system for monitoring specific TCR activation, as
demonstrated by stimulation of PB1-NJ76 by its cognate influenza-derived peptide and
stimulation of TRGV9/TRDV2 T cells with zoledronic acid (Zometa).
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Table 4-2.
CDR3 Amino Acid Sequences of Paired Human TRGV9/TRDV2 Cells
Isolated from PBMCs (n=14).
Paired Amino Acid Sequence in
TRGV9-CDR3 Region
ALFIQELGKKIKV

Paired Amino Acid Sequence in
TRDV2-CDR3 Region
ACDVLGDTEGRLI

ALWDGPYYKKL

ACDTVFTGGYSSWDTRQMF

2

ALWDIPPGQELGKKIKV

ACDTLGETSSWDTRQMF

2

ALWEAQELGKKIKV

ACDSGGYSSWDTRQMF

2

ALWEARQELGKKIKV

ACDTLFPGGSATDKLI

2

ALWEGTRGQELGKKIKV

ACDTVGAHTDKLI

2

ALWEVGDQELGKKIKV

ACDPLNTGGSFSLYTDKLI

2

ALWEVHSELGKKIKV

ACDTGGFRSSWDTRQMF

2

ALWEVHSELGKKIKV

ACDTGGFRSSWDTRQMF

2

ALWEVLELGKKIKV

ACDTVGMGIRLGDKLI

2

ALWEVLVGELGKKIKV

ACDILGINTDKLI

2

ALWEVPELGKKIKV

ACERLGDYVPDKLI

2

ALWEVQELGKKIKV

ACDRLLGDTDKLI

2

ALWEVQELGKKIKV

ACDTVAPRIGGLKYTDKLI

2

ALWEVQELGKKIKV

ACDTVGGPYTDKLI

2

ALWEVQELGKKIKV

ACDTVGGTAQ

2

ALWEVQELGKKIKV

ACDTVSGGSTPTWYTDKLI

2

ALWEVQELGKKIKV

ACDTVSIFTGDTTDKLI

2

ALWEVRELGKKIKV

ACDTILIFSPTGGDTDKLI

2

ALWEVRELGKKIKV

ACVPLGDWTDKLI

2
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Frequency
2

Table 4-2.

Continued.

Paired Amino Acid Sequence in
TRGV9-CDR3 Region
ALWEVRKQELGKKIKV

Paired Amino Acid Sequence in
TRDV2-CDR3 Region
ACDTLGDDFDKLI

ALWEVTHNRQELGKKIKV

ACDTLLGTEAWDTRQMF

2

ALWGGAAGAYYKKL

ACDGKTTDTDKLI

2

ALWGGELGKKIKV

ACDLLGDTRYTDKLI

2

ALWVQELGKKIKV

ACVGITGDTDKLI

2

ALWEAHQELGKKIKV

ACDSLGDSVDKLI

1

ALWEANKKL

ACDLLRGAGGQIDKLI

1

ALWEAQELGKKIKV

ACDTVGGAFDTDKLI

1

ALWEATGLGKKIKV

ACDMGDTRSWDTRQMF

1

ALWEDLELGKKIKV

ACDTVSWGKNTDKLI

1

ALWEKEELGKKIKV

ACDTGDWGSSWDTRQMF

1

ALWEKELGKKIKV

ACDILDSTGGTDLTAQLF

1

ALWEMTQELGKKIKV

ACDTVRNTGGYAFAGIDKLI

1

ALWEPQELGKKIKV

ACDKVLGDSSWDTRQMF

1

ALWESKELGKKIKV

ACEGLGATQSSWDTRQMF

1

ALWEVGELGKKIKV

ACDKLLGDNELI

1

ALWEVHKLGKKIKV

ACDSLLGKGTDKLI

1

ALWEVKELGKKIKV

ACDTLRGSADKLI

1

ALWEVLQQELGKKIKV

ACDTVPARHTDKLI

1

ALWEVPVLGKKIKV

ACDTADRSSYTDKLI

1

ALWEVQELGKKIKV

ACDTLLGDPSSSWDTRQMF

1
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Frequency
2

Table 4-2.

Continued.

Paired Amino Acid Sequence in
TRGV9-CDR3 Region
ALWEVQELGKKIKV

Paired Amino Acid Sequence in
TRDV2-CDR3 Region
ACDTLSGGYARTDKLI

ALWEVQELGKKIKV

ACDTVGILGDTGLGLI

1

ALWEVRELGKKIKV

ACDTIVSGYDGYDKLI

1

ALWEVRELGKKIKV

ACSILGDKTSDKLI

1

ALWEVRQELGKKIKV

ACDTVSQRGGYSDKLI

1

ALWEVRVQELGKKIKV

ACDPLERVGGPANTDKLI

1

ALWEVTELGKKIKV

ACDVLGDTGDDKLI

1

ALWGRELGKKIKV

ACDTVGSNTDKLI

1

ALWVQELGKKIKV

ACDVLGDTEADKLI

1

ALYGSPSGEELGKKNQG

ACDPLEGAGGHNTDKLI

1
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Frequency
1

Figure 4-6. Schematic Strategy of CDR3 Substitution by Overlap Extension PCR.
Based on the library of TCRαβ and TCRγδ established by the described cloning platform,
the strategy for CDR3 substitution using multiplex single cell PCR products and linker
DNA is shown. After the sequence analysis of single-cell PCR, the target pairs of TCRs
are chosen from the respective second round paired PCR plates, which include TCRα/γm
and TCRβ/δn (m represents a particular TRAV or TRGV subfamily; n represents a
particular TRBV or TRDV subfamily). Beforehand, we generated a library of linker
DNA by gBlock synthesis (IDT) (Table 2-6). The linker DNA consists of TRAC/TRGC2A-TRBVn/TRDVn (n represents the TRB/DV subfamily) sequence. Using the single
cell PCR products of α/γ and β/δ chains of the desired clonotypes and the relevant linker
gBlock DNA, we carried out an overlap PCR with TRAm/GVm internal sense primer and
TRB/DC internal antisense primer. The PCR products were visualized on an agarose gel,
and subsequently purified to use as “mega-primer” for cloning into the existing construct
from our TCR cloning library (pMIC- TCRα/γm- TCR β/δn) with the same TRGV and
TRDV family usage but different CDR3s by overlap extension PCR. The timeline of the
whole process is on the left.
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Considering the variability of CDR3 sequences and TCR variable regions
(approximately 1018 combinations in human TCRγδ cells and 1016 combinations for
TCRαβ cells (Chien et al., 2014)) and the complexity of cloning all the different clones
de novo, we established a method using overlap extension PCR of a linker molecule with
amplified single cell CDR3 products and a constructed γδ TCR library to rapidly (less
than 5 days) generate diverse TCR clones. The applications of this rapid approach for
immunotherapy are obvious. Tumor-specific T cells have been characterized by broad
non-specific surface phenotypes that can be used to isolate, clone, and express potential
tumor-targeted clones (Gros et al., 2014). The recent advancement of tumor sequencing
has allowed for identification of tumor neoantigens and overexpressed self-antigens
(Downing et al., 2012; Robinson et al., 2012; Zhang et al., 2012a, 2012b). Combining
these technologies will allow for promptly characterized and tailored anti-tumor therapy.
T cell transfers have also been used for the treatment of opportunistic infections in
immunosuppressed patients, particularly after hematopoietic stem cell transplant. The
reactivation of herpes viruses like human cytomegalovirus and Epstein-Barr virus is a
clinical dilemma that cannot always be addressed with antivirals (Barrett and Bollard,
2015; Perko et al., 2015; Saglio et al., 2014). Analogous to TIL therapies, ex vivo
expansion of antiviral T cell specificities can be clinically useful, but suffers from similar
workflow limitations. By generating a library of specific TCR constructs reactive against
a range of viruses and HLA types, TCR-directed therapies could be used prophylactically
or immediately at the earliest signs of reactivation.
In addition to these therapeutic applications, our protocol significantly improves
the workflow for cloning and expressing TCRs for study in vitro. This can include the
characterization of biochemical features of the TCR-peptide-MHC interaction, or, in the
case where ligands have not been identified, transduced cell lines can be used for the
screening of novel antigens. This is particularly useful in the context of γδ T cells, where
very few ligands have been identified and confirmed (Vantourout and Hayday, 2013;
Vavassori et al., 2013). The GFP reporter line we have engineered can be used directly in
high-throughput screening platforms; alternative reporters (such as luciferase) can be
easily substituted as well.
In conclusion, we introduce a novel method to rapidly clone, express and
characterize the function of paired αβ and γδ TCR chains from single cells. Our platform
addresses the non-specific, labor-intensive, and time-consuming issues of traditional
PCR-based cloning and it provides a relatively high-throughput, accurate, and efficient
method of TCR engineering for therapeutic or research applications.
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CHAPTER 5.

DISCUSSION

Infants suffer higher rates of hospitalization and mortality after influenza virus
infection, compared to young adults. It has been reported that infants cannot mount
robust type 1 immune responses, due to the insufficient magnitude and function of
neonatal CD8 T cells (You et al., 2008). Therefore, the unique type 2-biased immune
system potentially makes the treatment to neonates different from that to adults, perhaps
as a mechanism limiting potential inflammatory damage. To further characterize the
neonatal immune responses to influenza infection, we found γδ T cells develop and
migrate to mucosal organs prior to αβ T cells during the immune response, suggesting
that the former may play a critical role in immune competence in neonates (Chien et al.,
2014; Hayday, 2000; Vantourout and Hayday, 2013). Here, we demonstrated the critical
role for γδ T cells in maintaining lung homeostasis and tissue integrity during neonatal
influenza infection.
As reported previously, adult γδ T cells respond to influenza infections by
producing IL-17A and IL-17F to initiate lung inflammation, which is immuno-pathogenic
to the infected hosts (Crowe et al., 2009; Li et al., 2012). In contrast, other groups have
shown that γδ T cells can induce robust humoral responses and protect adults from
influenza infections (Dong et al., 2018; Wang et al., 2011, 2016). However, in neonates,
we found the primary function of γδ T cells in this model of influenza infection appears
to be the rapid production of IL-17A to initiate a cascade of type 2 and tissue repair
responses, which were characterized by the induction of IL-33, the recruitment of ILC2s
and Treg cells, and the production of amphiregulin for the tissue repair and homeostasis.
To determine if the γδ T cells can also protect adults, we infected wild-type and
Tcrd-/- adult mice with H1N1 influenza virus, but we did not observe a significant
difference between these two groups in the weight loss and survival. We found that adult
γδ T cells can also produce IL-17A following influenza infections, while the peak of the
response is at the relative late stage of the infections (Day 5-8), which may be the reason
why it leads to a different disease outcome in adults, compared to the infected neonates.
We speculate that the lung environment, biased to type 2 immunity, and the compacted
lung structure can cause the different responses from γδ T cells.
Interestingly, one recent study has also suggested IL-17A-producing γδ T cells
can modulate regulatory T cell homeostasis and thermogenesis in adipose tissues by
inducing IL-33 production from fibroblasts, which further confirms the novel IL-17A-IL33 axis that we identified in our study (Kohlgruber et al., 2018). In addition, another
study has reported an exacerbation of IL-33 production after IL-17A administration, but
this was in a model of allergic asthma, where the effects of IL-17A were primarily
pathological (Mizutani et al., 2014). This unconventional function of IL-17A to induce
type 2 immunity, which is commonly considered to regulate type 3 immunity in bacterial
infections (Cheng et al., 2012; Lockhart et al., 2006), is perhaps a fine-tuning mechanism
from the innate immune cells for balancing pro-inflammatory type 1/17 immunity and
anti-inflammatory type 2 immunity for tissue repair and homeostasis.
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An important factor previously identified involved in neonatal immunity is the
potential effect of environmental variation, such as microbiota (Cicin-Sain et al., 2012).
Indeed, in our own experiments we have observed differences in neonates reared by
different wild-type and Tcrd-/- dams. These observations suggest that γδ T cells may
regulate additional features of immunity via breast milk or some other maternal factor.
To avoid such confounding factors in the experiments reported here, all γδ T cell- and
IL-33-deficient mouse studies were performed with heterozygous parents and utilized
comparisons of littermate controls.
Although γδ T cells respond to neonatal influenza infections rapidly, we have not
identified any ligands that γδ T cells can recognize upon the infections. Similar to αβ
TCR, γδ TCR can be stimulated by the peptides presented by MHC I. Interestingly, it has
also been reported that Vγ9Vδ2 cells can recognize phospholipids mediated by
butyrophilin 3A1 (BTN3A1), which is a ubiquitously expressed cell surface protein
(Willcox and Willcox, 2019). Therefore, identifying the ligands for γδ T cells can be
different from the current methods for αβ T cells.
In addition, as innate-like lymphocytes, it is potentially intriguing to determine if
γδ T cells have immunological memory. One study has indicated that γδ T cells can
generate a bacteria-specific memory response following Listeria monocytogenes (Lm)
primary and secondary infections (Sheridan et al., 2013). The intestinal γδ T cells, which
are mainly IL-17A and IFN-γ producing cells, exhibit more robust cell expansion and
cytokine production after secondary challenge. Therefore, studying if influenza can also
induce the generation and functions of memory γδ T cells and how we can manipulate
this population has a great potential in the treatment to infections.
In conclusion, our findings provide evidence that IL-17A, secreted by γδ T cells,
has a critical function in protecting infants during influenza infection. IL-17A-producing
γδ T cells may provide this protection by inducing IL-33 secretion and type 2 immune
responses which, in turn promote tissue homeostasis and integrity.
Nevertheless, the ligands for γδ T cell activation in this system are undetermined.
Therefore, we developed techniques for studying TCRs and their ligands, including
single-cell based protocol for γδ TCR amplification, a rapid protocol for TCR cloning
and expression, and a novel platform for functional characterization of TCR clones. Our
system provides an accurate and efficient method to approach rapid cloning at the single
cell level, which can improve the development of multiple applications, including TCRmediated immunotherapy and high-throughput ligand screening for antigen-specific
TCR.
Adoptive cell transfer therapy has been considered as one of the most prominent
immunotherapy approaches recently. However, the current protocols for defining paired
TCR repertoire and cloning the antigen-specific TCRs are still less efficient, laborintensive and time-consuming, while the key to the application of T cell immunotherapy
is the rapid and accurate isolation and cloning of paired TCRs. Our methods provide
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efficient acquisition of TCR gene products for cloning based on single cell isolation
(approximately 70-80% of total sorted single cells in each sample).
Following TCR analysis and characterization, the discovery of ligands to the
antigen-specific T cells is another important application of our methods. By stably
expressing Nur77-GFP or Nur77-Luciferase in Jurkat 76 TCRα-β- cell line, we can
identify molecules that specifically trigger TCR signaling based on different TCRs
expressed on the surface of the Jurkat cells, as demonstrated by stimulation of PB1-NJ76
by its cognate influenza-derived peptide and stimulation of TRGV9/TRDV2 T cells with
zoledronic acid (Zometa). Thus, our methods of determining TCR ligands will provide a
powerful tool for therapeutic applications.
In conclusion, this dissertation has suggested a protective role of IL-17Aproducing γδ T cells in neonatal influenza infections via initiating downstream effects on
IL-33 induction by lung epithelial cells and further amphiregulin secretion by lung
regulatory T cells and group 2 innate lymphoid cells for tissue repair and homeostasis.
Additionally, this dissertation introduces a novel platform to rapidly clone, express and
characterize the functions of paired αβ and γδ TCR chains from single cells. Altogether,
our findings shed more lights on the potential treatment of infant respiratory infections
and research applications.
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